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ABSTRACT 
Hypertensive disorders are one of the leading causes of maternal morbidity and mortality in South 
Africa.  The  morbidity and mortality rate can be decreased by early detection and management of 
hypertensive disorders at primary health care Level. The midwives should therefore be 
knowledgeable and competent in the assessment and diagnosis of pregnant women who are at 
risk of developing a hypertensive disorder, and be able to manage the problem. 
The purpose of the study was to investigate scientifically the knowledge of the registered midwives 
managing hypertensive disorders in pregnancy working at primary health care level in the Eastern 
Cape. 
The objectives set for the study were to investigate the knowledge of the registered midwives in the  
following areas: 
• Knowledge about hypertensive disorders 
• Assessment  
• Diagnosis   
• Management 
A descriptive correlational research design was applied with a quantitative approach to investigate 
scientifically the knowledge of the registered midwives  managing hypertensive disorders in 
pregnancy.  The target population included all the registered midwives working permanently in 
primary health care clinics in the Buffalo City Local Service Area. A stratified random sample of 
n=43 (44%) of a population of N=98 clinics  both in rural and urban were selected together with a 
sample of n=101(44%) of N=228 registered midwives working in these clinics.  A questionnaire 
consisting of  predominantly closed questions was used for the collection of data, collected 
personally by the researcher. Ethical approval was obtained from  Stellenbosch University, 
Department of Health and individual informed consent.  A pilot study, which did not form part of the 
study, was conducted to test the questionnaire at the clinics. A 10% (n=10) sample of the 
registered midwives of 4 clinics participated in the pilot study. The validity and reliability was 
assured through the pilot study, the use of a statistician, as well as experts in midwifery, nursing 
and a research methodologist. 
The data was analysed and presented in tables and histograms. Statistical correlational tests were 
done to determine any correlations between the variables. Findings obtained show that inadequate 
knowledge exists among participants with specific reference to knowledge, assessment, diagnosis 
and management about hypertensive disorders.  A statistical correlation was shown between the 
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presence of doctors and the knowledge of the midwives using the Mann-Whitney statistical test 
(p=0.04). In clinics where there are no doctors’ visits,  the knowledge of the staff was higher 
(0.691), than the total knowledge mean score (0.666). Where doctors are regularly visiting the 
clinics the mean knowledge score is lower (0.656). These results show that where midwives do not 
have any additional support as when there are doctors present, individual effort is made to keep up 
to date as they are practising as independent practitioners.  
Recommendations are based on the scientific evidence which emphasis further education in 
advanced midwifery, workshops, conferences, updating their knowledge and weekly in-service 
training, introduction of a quality assurance and patient education programmes.   
In conclusion empowering the midwives with the required knowledge about hypertensive disorders 
will contribute towards decreasing the mortality and morbidity rates. 
 
 
vi 
 
 
OPSOMMING 
Siektetoestande gekoppel aan hipertensie is een van die vernaamste oorsake van sieklikheid en 
moedersterftes in Suid-Afrika. Die siektetoestand en sterftekoers kan afneem deur vroeë opsporing 
en bestuur van hipertensietoestande  op primêre gesondheidsorgvlak. Die kraampersoneel 
behoort dus kundig en bekwaam te wees tydens die assessering en diagnose van swanger vroue 
wat die risiko loop om ’n toestand van hipertensie te ontwikkel en daartoe in staat te wees om die 
probleem te kan hanteer. 
Die doel van die studie is om die kennis van geregistreerde vroedvroue  wetenskaplike te 
ondersoek wat hipertensiewe toestande tydens swangerskap hanteer  op Primêre 
Gesondheidssorgvlak in die Oos-Kaap. 
Die doelstellings wat uiteengesit is vir die studie, is om die kennis van  geregistreerde 
kraampersoneel in die volgende areas te ondersoek: 
• Kennis van hipertensiewe toestande 
• Assessering 
• Diagnose 
• Hantering. 
’n Beskrywende korrelerende navorsingsontwerp is toegepas met ’n kwantitatiewe benadering om 
die kennis van die geregistreerde kraampersoneel wat  hipertensiewe versteurings in 
swangerskappe hanteer, wetenskaplik te ondersoek. Die teikengroep het al die geregistreerde 
kraampersoneel wat permanent in die primêre gesondheidssorgklinieke in die Buffalo City 
Plaaslike Diensarea werk, ingesluit. ’n Gestratifieerde ewekansige steekproef van n=43 (44%) 
gekies uit ’n gesamentlike plattelandse en stedelike bevolking van N=98 klinieke met ’n steekproef 
van n=101 (44%) van N=228 geregistreerde vroedvroue wat  in die klinieke werk. ’n Vraelys wat 
hoofsaaklik uit geslote vrae bestaan, is gebruik vir die insameling van data wat persoonlik deur die 
navorser ingesamel is. Etiese toestemming is verkry van die Universiteit Stellenbosch,  die 
Departement van Gesondheid asook individuele ingeligte toestemming. ’n Loodsondersoek is 
uitgevoer om die vraelys te toets by die klinieke wat nie deel van die studie was nie. ’n 10% (n=10), 
steekproef van die geregistreerde vroedvroue van 4 klinieke het deelgeneem aan die 
loodsondersoek. Die geldigheid en betroubaarheid is verseker deur die loodsondersoek, die 
gebruik van ’n statistikus asook kundiges in kraamverpleging en ’n navorsingsmetodoloog. 
Die data is geanaliseer en weergegee in tabelle en histogramme, statistiese korrelasietoetse is 
gedoen om korrelasies te bepaal tussen die veranderlikes. Die bevindings, bewys dat  
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ongenoegsame kennis bestaan by deelnemers met spesifieke verwysing na kennis, assessering, 
diagnose en hantering ten opsigte van aangaande toestande van hipertensiewe toestande. ’n 
Statistiese korrelasie is getoon tussen die teenwoordigheid van geneeshere en die kennis van 
vroedvroue deur gebruik te maak van die Mann-Whitney statistiese toets (p=0.04). In klinieke waar 
daar geen doktersbesoeke is nie, is die personeelkennis beter (0.691) as die totale gemiddelde 
kennistelling (0.666). Waar geneeshere gereeld die klinieke besoek, is die gemiddelde 
kennistelling laer (0.656). Hierdie resultate bewys dat waar die vroedvroue geen bykomende 
ondersteuning deur die teenwoordigheid van geneeshere het nie, het individuele moeite  gedoen 
om op die hoogte te bly, aangesien hulle as onafhanklike praktisyns optree. 
Aanbevelings is gebaseer op wetenskaplike bewyse wat verdere onderrig beklemtoon in 
gevorderde kraamverpleging, werkswinkels, konferensies, die bywerk van kennis en weeklikse 
indiensopleiding, die instel van ’n kwaliteitsversekering en opvoedingsprogramme vir pasiënte. 
Ten slotte die  bemagtiging van vroedvroue wat oor die vereiste kennis beskik van toestande van 
hipertensiewe toestande, sal bydra tot die afname van sterfte- en siektesyfers. 
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CHAP TER 1: SCIENTIFIC FOUNDATION FOR THE STUDY 
1.1  INTRODUCTION 
An increase in maternal mortality has become a national issue for midwifery. Maternal mortality 
can be defined as the death of a woman while pregnant or within 42 days of termination of 
pregnancy. This is irrespective of the duration of pregnancy, from any cause related to or 
aggravated by the pregnancy or its management but not from its accidental or incidental causes 
(World Health Organization, 2005:4). 
In South Africa, according to the Confidential Enquiry Report into Maternal Deaths, the national 
statistics of 2002 to 2004 reports a 48% morbidity and 19.1% mortality rate. The main causes of 
maternal mortality and morbidity are hypertensive disorders (Strategic Plan of Department of 
Health, 2004:17). According to Lowdermilk and Perry (2007:785), hypertension is the second 
leading cause of maternal and perinatal morbidity in the United States of America. In the UK 
hypertensive diseases of pregnancy remains the second leading cause of direct maternal deaths 
(Patient United Kingdom, 2006:2-3). 
The National Department of Health’s (NDoH) goals for child health are guided by 
international child health goals, including the reduction of infant and child mortality and morbidity. 
Targets have been set according to the millennium development goals which include reducing child 
/ infant mortality rate (IMR) by two thirds between 1990 and 2015 (Strategic Plan of Department of 
Health, 2005). According to the South African midterm report on the Millennium Development  
Goals objectives also include reducing the neonatal mortality rate (NNMR) from 20 to 14 per 1 000 
live births, ensuring that the national IMR does not exceed 45 per 1000 live births and reducing the 
national U5MR to 59 per 1000 live births . 
The goal of the Department of Health in the Eastern Cape is aligned to the NDOH’s goals and that 
is to decrease morbidity and mortality rates in the province. These goals could be achieved 
through strategic interventions by improving the quality of care and promoting integration of 
government interventions at all levels of the Health System to ensure synergistic and effective 
service delivery (National Committee For The Confidential Enquiry into Maternal Death,1999-
2004:19).  
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1.2  RATIONALE 
The incidence of hypertensive disorders in the Eastern Cape Buffalo City Local Service Area is 
19.2% of which approximately 5% developed eclampsia (Strategic Plan of the Provincial 
Department of Health, 2001-2004:17). 
Hypertensive disorders are one of the leading causes of maternal morbidity and mortality in South 
Africa (National Maternity Care Guidelines Committee of the Department of Health, 2003:56).  
According to the statistics of the Eastern Cape Department of Health the percentage of maternal 
mortality and morbidity rate due to hypertensive disorders is 53% ( Strategic Plan  of the Provincial 
Department of Health, 2004-2007:19). 
During clinical accompaniment of the midwifery students i.e. students following the four year 
diploma and one year programme  respectively, it was observed  that a high incidence of 
hypertensive disorders exist amongst the pregnant women in the Buffalo City  Local Service Area 
in Amathole District Municipality. This is supported by the following statistical evidence obtained at 
an antenatal clinic as shown in table 1. 1. 
The total attendance for 2004 was 7219, of which 12% (872) of all patients were hypertensive.  
The total attendance of the patients who attended for 2005 was 5924 of which 19.5% (1158) of the 
patients were hypertensive.  
Over a period of eight months, January 2006 - August 2006,  5353 patients attended the antenatal 
clinic of which 18.8% (1008) of all patients were hypertensive. These statistics show a marked 
increase in patients diagnosed with hypertensive disorders. According to the National Committee 
for the Confidential Enquiry into Maternal Deaths (1999:-2001:71), mortality rate can be decreased 
by early detection and management of hypertensive disorders at primary health care level. The 
midwives should therefore be knowledgeable and competent in the assessment and identification 
of pregnant women who are at risk of developing hypertensive disorders and in the management of 
those who have been identified.  
Table 1.1: Patients diagnosed with hypertension for the period 2004-August 2006 
Period Patient Attendance Diagnosed with  Hypertension 
2004 7219 872 (12%) 
2005 5924 1158 (19.5%) 
Jan 2006-Aug 2006 
(8 months) 
5353 1008 (18.8%) 
18 
 
 
World-wide hypertensive disorders have an adverse effect on maternal morbidity and mortality, as 
well as on  fetal and infant mortality as shown in various studies. Chhabra and Kakani (2007:25), 
state that hypertensive disorders continue to be a major cause of maternal and fetal morbidity and 
mortality rates. It accounts for many admissions, labour inductions and operative intervention for 
complications in order to reduce mortality. Supported by Gómez, Martínez, Figueras,  Del Río  
Borobio,  Puerto,  Coll, Cararach, Vanrell  (2005:490), hypertensive disorders and associated 
complications are responsible for a significant proportion of perinatal and maternal morbidity and 
mortality during pregnancy.  Furthermore,  it was identified in the Caribbean that hypertensive 
disorders is the major contributor to maternal deaths.  The reduction of maternal deaths is a high 
priority for the international community, especially in view of the increased attention on  the 
Millennium Development Goals (Khan,  Wojdyla, Say, Gülmezoglu and  Van Look, 
2006:1066). In Africa, hypertensive disorders are also contributing adversely to the maternity 
mortality and morbidity, as identified in a study in Sudan, to be the main contributing factor to 
maternal mortality. The researchers also found that hypertensive disorders of pregnancy 
decreased to 8.4%, due to better antenatal care (Dafallah, El-Agib and Bushra, 2003:369-372). 
Observations made by the researchers in the Indian rural regions showed that 32.2% of the 
perinatal loss was as a result of hypertensive disease. In this study perinatal mortality is mostly 
associated with low birth weight, which could be because of spontaneous or induced preterm 
delivery for fetal, maternal or feto-maternal reasons (Chhabra, Qureshi and Datta, 2006:532). 
According to Moodley (2004:247), there were 507 deaths associated with hypertensive disorders of 
pregnancy in South Africa during the period 1999-2001. Most deaths from eclampsia occurred at 
parity of 0, namely 51%. He identified factors that played a major role in mismanaging hypertensive 
disorders of pregnancy, such as delay in referral due to unavailability of transport, lack of protocol 
for the management of eclampsia and failure to follow clinical protocols of care all contributed 
towards avoidable medical factors. In addition he also identified in a population based study in 
Durban hypertensive disorders which contributed to 12% of all cases seen, which were aggravated 
by various problems such as administrative problems, lack of transport to clinics, barriers to access  
health care facilities, lack of accessibility, such as a lack of termination of pregnancy and a lack of 
appropriately trained staff. In this study it was shown that the age groups mostly affected are:  
22.8% were 20 years of age, 47% were 24 years of age and 58.6% were between ages of 25 and 
34 years. 
Hypertension complications occur in 8% to 10% of all the pregnancies and contribute significantly 
to maternal and neonatal morbidity and mortality worldwide (Mugo,Govindarajan, Kurukulasuriya, 
Sower and Mcfarlane, 2006:348-350). Ideally, prediction, detections and prevention of severe pre-
eclampsia reduces morbidity and mortality. This is further substantiated by Zareian (2004:194-
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198), who emphasised that more attention is required to assess  pregnant women by detecting and 
preventing the complications..The hypertensive disorders of pregnancy commonly complicate 
pregnancy and have great influence on maternal and neonatal morbidity and mortality rates. 
Furthermore, hypertensive disorders of pregnancy, pre-eclampsia and gestational hypertension are 
associated with increased risk of future chronic hypertension (Wolf, Shah, Jimenenz- Kimble, 
Sauk, Ecker and Thadhani, 2004:1330-1338). 
Peters and Flack (2003:209), conclude that nurses working in outpatient, home care and acute 
care settings, must be vigilant when assessing pregnant women so that hypertensive problems are 
identified early and treated promptly. Furthermore, nurses must have knowledge about the 
procedures required to ensure accuracy and make informed decisions based on this knowledge. 
Adequate management of these women will promote  safe and healthy deliveries. Prevention of 
hypertensive disorders in pregnancy requires nurses to use their assessment, advocacy and 
counseling skills. 
In a study of 615 patients affected by hypertension during pregnancy, findings showed that 347 
cases were diagnosed with severe pre-eclampsia and 132 cases were diagnosed as HELLP 
(Haemolysis, elevated liver and low platelet count) syndrome. The findings of this study showed 
that approximately 2% to 5% of all pregnancies are complicated by pre-eclampsia, with 
hypertensive disorders being a main cause of maternal morbidity and mortality. All these findings 
point out that timely diagnosis and appropriate intervention is lifesaving and can improve maternal 
and fetal outcomes (Gul, Aslan, Cebeci, Polat, Ulusoy and Ceylan, 2004:557-562). 
It was identified in the literature and observed in the clinical environment that various treatment 
measures are recommended to manage hypertensive disorders. 
Emery (2005:348), suggests magnesium sulfate for prevention and arresting of eclamptic seizures. 
Repke, Power, Holzman and Schulkin (2002:472), found success in the use of low-dose aspirin 
and calcium supplements during the antenatal period and magnesium sulfate during labour. In 
addition Patient United Kingdom (2006:2-3), also found that low dose aspirin and calcium 
supplementation appear to reduce the risk of high blood pressure in pregnancy. 
However, antihypertensive drugs are used solely to prevent maternal morbidity and have no effect 
on disease progression. Frishman,, Schlocker, Award and Tejani (2005:274), propose that calcium 
supplements can reduce the incidence of pre-eclampsia, while others have investigated the use of 
vitamin C and E to prevent pre-eclampsia in woman at high risk. Mugo, Govindarajan, 
Kurukulasuriya, Sowers and Mcfarlane (2006:348-350), in their studies found both vitamins C and 
E to reduce rates of pre-eclampsia in patients with abnormal uterine doppler studies.  
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Hydralazine and methyldopa are used in combination, as methyldopa has an adverse effect to the 
side effects of hydralazine. Zareian (2004:194-198), also supports the use of hydralazine and 
magnesium sulfate.  
McCaw-Binns, Ashley, Knight, MacGillivray and Golding (2004:286-294),  developed strategies to 
prevent eclampsia in a developing country. This study was aimed at reducing maternal morbidity 
and mortality. Effects of these strategies developed for prevention of hypertension in pregnancy 
resulted in a dramatic reduction in admission for pre-eclampsia, with a subsequent drop in the 
number of bed days used for eclampsia. Primary health care level antenatal clinics had clear 
instructions for referring patients to a high risk antenatal clinic or to a hospital which included the 
following:  
• Guidelines  provided to high risk clinics and antenatal wards for appropriate treatment of 
hypertension and eclampsia.  
• Midwives,trained in primary health care, public health nurse and community health aids to 
identify and follow up women at risk of developing hypertension in pregnancy.  
• Posters and books providing information to pregnant women ..  
• Guidelines issued to midwives on techniques of taking blood pressure and doing a urine 
analysis.  
• Frequent meetings held with midwives to feed information back to the staff and facilitate the 
exchange of information between primary and secondary health care level in order to solve 
problems as they were identified.  
• The private practitioners provided with information to ensure early referral of woman with 
signs of hypertension or pre-eclampsia.  
• Furthermore, it is imperative that all women should receive antenatal education so that they 
are aware of the symptoms associated with pre-eclampsia. Alcohol and tobacco use should 
be strongly discouraged (Patient United Kingdom, 2006:2-3).  
1.3 PROBLEM STATEMENT 
On the basis of the above information it appears that there could be a deficit in the knowledge of 
the professional registered midwives about the assessment, diagnosis and management of the 
hypertensive disorders in pregnant women. It is therefore imperative to evaluate scientifically the 
knowledge of the midwives working at primary health care level regarding the knowledge, the 
assessment, diagnosis and management of hypertensive disorders in pregnancy. 
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1.4 RESEARCH QUESTION 
As a departure point for this study, the researcher poses the question; “Do the registered 
midwives, working at primary health care level, have adequate knowledge of the management of 
hypertensive disorders in pregnancy?” 
1.5 GOAL  
The purpose of this study is to investigate scientifically the knowledge of the registered midwives 
managing hypertensive disorders in pregnancy working at primary health care level in the Buffalo 
City Local Service Area of the Eastern Cape. 
1.6 OBJ ECTIVES 
To determine whether the registered midwives working in primary health care have adequate 
knowledge about 
a. hypertensive disorders in pregnancy 
b. the assessment of hypertensive disorders in pregnancy  
c. the diagnosis of hypertensive disorders in pregnancy   
d. the management of hypertensive disorders in pregnancy.  
1.7 RESEARCH METHODOLOGY 
1.7.1  Res ea rch des ign   
A descriptive correlational non-experimental research design will be applied with a quantitative 
approach to investigate scientifically the knowledge of the registered midwives managing 
hypertensive disorders in pregnancy and working at primary health care level in the Eastern Cape.  
According to Burns and Grove (2009: 696; 2007:537), a research design is a “blueprint” for 
conducting a study which ensures the validity of the findings by maximizing the control over factors 
that could influence it. A correlational design is described as a systematic investigation of 
relationships between or among variables (Burns and Grove, 2007:25). 
During this study the actions and knowledge  of registered midwives in relation to management of 
hypertensive disorders will be described.  
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1.7.2 Popula tion and  Sampling 
Population is a collection of objects, events or individuals having some common characteristics 
that the researcher is interested in studying (Mouton 1996:134).  
Sampling is a process in which representative units of a population are selected for study in a 
research investigation (LoBionda-Wood and Haber: 2006:572). 
As shown in tables 1.2 and 1.3 Region C in the Eastern Cape consists of  98 clinics which include 
rural and urban clinics in the Buffalo City Local Service Area. A random sample of 43 clinics (44%), 
will be drawn from the total number of clinics. The researcher will use 28 clinics from the rural area 
and 15 clinics from the urban area. The clinics will be drawn randomly from a list of all the clinics, 
drawing every second clinic on the list until the desired number is obtained. The target population 
for this study is the registered midwives allocated in these clinics. In the rural clinics  2 registered 
midwives (RM), are allocated and in urban clinics  3 registered midwives are allocated per clinic. 
The total population of the registered midwives working in the Buffalo City Local Service Area is 
228.  The stratified random sample to be selected is 101 (44%) of the total population of the 
registered midwives.  Guided by the statistician a sample of at least 100 registered midwives is 
required.    
Table 1.2: Population and sampling of urban clinics and midwives  
Clinics Population 
(N) 
Sample (n) Population of 
RM (N) 
Sample of RM 
(n) 
Buffalo Municipality 28 13(47%) 84 40 (48%) 
4 Mdantsane 2(40%) 12 
TOTAL N 
5 (42%) 
32 15(47%) 96 45(47%) 
Table 1.3: Population and sampling of rural clinics and midwives 
Clinics Population 
(N) 
Sample (n) Population of 
RM (N) 
Sample of RM 
(n) 
Mdantsane 11 5 (45%) 22 11(50%) 
Peddie 23 9 (39%) 46 18 (39%) 
Bisho 23 9 (39% 46 18 (39%) 
9 East London 5 (55, 6%) 18 
TOTAL (N) 
9 (50%) 
66 28 (42%) 132 56 (42%) 
1.7.3 Pilo t s tudy  
A pilot study attempts to test the instrument for ambiguity and accuracy and is a trial run done in 
preparation for a major study (Polit & Hungler, 2001:467). According to LoBiando-Wood and Haber 
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(2006:569), it is a smaller version of the actual study conducted as a prelude to a larger scale 
study, but is often called the “parent study”.  Furthermore, the purpose of the study is to test the 
instrument for any inaccuracies, ambiguity and to assess the feasibility of the study. Only 10% of 
the actual sample is required as described in De Vos, Strydom, Fouche and Delport (2002:210). 
In addition as described by Burns and Grove (2009:44), a pilot study assists to develop or refine 
the research methodology, data collection and supports the reliability and validity of the research 
instrument. 
For this study a pilot study will be  conducted in four primary health care clinics in April 2009. A 
stratified sample of 10 (10%) participants will be randomly selected based on the actual size of the 
sample of the study, These participants and clinics will not form part of the actual study.  
1.7.4 Re liab ility and  Va lid ity 
Reliability of a study represents the consistency of the measure obtained while validity is the 
measure of the truth or accuracy of a claim. This is an important aspect throughout the research 
process (Burns & Grove, 2009:718- 727).   
A statistician was consulted with the design of the questionnaire, to assist with the planning of the 
data analysis and will be consulted throughout the study. Midwifery experts and a research 
methodologist were consulted to evaluate the content validity of the instrument. The reliability and 
validity of the study will be further assured by distributing the same instrument to 10 registered 
midwives during a pilot study.  Furthermore, the researcher will collect all data personally.  
1.7.5 Ins trume nta tion 
According to Burns and Grove (2009:704), instruments are measuring tools which adhere to 
specific rules when being developed,for example questions should be accurately stated with no 
ambiguity.  A structured questionnaire was designed based on an intensive literature review and 
the researcher’s clinical experience. It consisted of specifically closed questions. The questionnaire 
(Annexure A) was divided into various sections namely : 
• Biographical data: age, qualifications, gender and experience 
• Knowledge and diagnosis of hypertensive disorders: Different definitions of hypertensive 
disorders, risk factors of hypertensive disorders and effects 
• Assessment: Medical and social history, clinical manifestations, physical examination, and 
diagnostic tests 
• Management of hypertensive disorders including prevention and treatment.  
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1.7.6 Da ta  Co llec tion 
According to Burns and Grove (2007:536), data collection is the systematic gathering of 
information relevant to the research papers or specific objectives, questions or hypothesIs.  
For the purpose of this study the researcher will collect all data personally by handing out a 
structured questionnaire to individual participants and collecting it after completion in a sealed 
envelope. The data will be collected over a period of 4 weeks. 
1.7.7  Da ta  ana lys is  and  Inte rp re ta tion  
A statistician was consulted prior to application for ethical approval. The plan for the data analysis 
was based on the questionnaire with the support of Prof Kidd..It was decided that the data will be 
presented as frequencies, graphs and tables where applicable. Various statistical tests such as 
Spearman and Mann-Whitney tests will be applied to determine possible associations between 
variables.  
1.8 ETHICAL CONSIDERATIONS 
Consent was obtained from the Eastern Cape Department of Health, Annexure C and the Human 
Science Ethical Committee at the University of Stellenbosch (Annexure B) . Informed written 
consent (Annexure D) will be obtained from all participants. Confidentiality and anonymity will be 
assured. All data will be managed confidentially and will only be accessible to the researcher. It will 
be discarded five years after completion of the study. 
1.9 RECOMMENDATIONS  
Recommendations based on the scientific evidence will be made to the Eastern Cape Department 
of Health. The results of the study will be made available to all relevant parties involved in the 
study and will be publish. and be presented at research conferences.  
1.10 OPERATIONAL DEFINITIONS 
Chronic hypertension is diagnosed before 20 weeks of gestation (Lowdermilk & Perry, 
2007:786). 
Eclampsia is the onset of seizure activity or coma in the woman diagnosed with pre-eclampsia 
with no history of existing pathology (Lowdermilk & Perry, 2007: 786 ). 
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Maternal mortality:  can be defined as the death of a woman while pregnant or within 42 days of 
termination of pregnancy, irrespective of the duration and site of pregnancy, from any cause 
related to or aggravated by the pregnancy or its management, but not from its accidental or 
incidental causes (World  Health  Organization, 2005:4). 
A midwife is a person who is qualified and competent to independently practise midwifery in the 
manner and to the level prescribed and who is capable of assuming responsibility and 
accountability for such practice and registered as such in terms of section 31 (South African 
Nursing Council Act No 33 2005:5). 
Morbidity refers to an illness or abnormal condition (Mosby’s Medical, Nursing and Allied 
Dictionary, 2002:1120). 
Pre-eclampsia refers to a pregnancy specific syndrome in which hypertension develops after 
twenty weeks of gestation in a previously normotensive woman, characterized by the presence of 
hypertension and proteinuria (Lowdermilk & Perry, 2007:785).  
Pregnancy is the gestational process, comprising the growth and development within a woman of 
a new individual from conception through the embryonic and the fetal periods to birth (Mosby’s 
Medical, Nursing and Allied Dictionary, 2002:1389).   
Primary health care is essential health care based on practical, scientifically sound and socially 
acceptable methods and technology, made universally accessible to individuals and families in the 
community, through their full participation and at a cost that the community and the country can 
afford to maintain at every stage of their development in the spirit of self-determination (Smeltzer & 
Bare,2000:489) 
1.11 STUDY OUTLAY 
Chapter 1: In this chapter the scientific foundation of the study is discussed with an in-depth 
overview of the research methodology to be followed. 
Chapter 2: A literature review is discussed based on the hypertensive disorders. 
Chapter 3: The research methodology as planned and discussed in chapter 1 is described as 
implemented.  Any limitations to the study are described, actual duration of collection of data and 
interviews are discussed. 
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Chapter 4: Data analysis, interpretation discussion of the findings are described. Data is presented 
in frequencies, tables or graphs. Various statistical associations between variables are also 
described. 
Chapter 5:  Various recommendations based on the scientific evidence are described. 
1.12 CONCLUSION  
In this chapter the rationale based on deductive and inductive reasoning, supported with the 
literature, problem statement, research question, goal, objectives and research methodology for 
the study is described.  
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CHAP TER 2: LITERATURE REVIEW 
2.1 INTRODUCTION 
The literature reviewed and presented in this chapter focused on the literature which deal with the 
framework of this particular study. The reviewed literature helped to predict the success of the 
proposed study, and to identify a need for further research in this particular area.  The literature 
also provided the researcher with a context for examining the problem under study.  
2.2 HYPERTENSIVE DISORDERS IN PREGNANCY  
According to Leerners, Neumaier-Wagner, Kuse, Irawan, Imthurn and Rath (2005:442), 
hypertensive diseases in pregnancy are one of the leading causes of fetal and maternal morbidity 
and mortality. Twenty percent of perinatal deaths in the United States of America with a well 
established medical system occur as a result of hypertensive diseases in pregnancy. In their study  
it was shown that women who develop hypertensive diseases in pregnancy may have 
characteristic features in their family structure as a child.  
Chhabra and Kakani (2007:25-29), has reported that worldwide between 40000-70000 maternal 
deaths occur annually due to severe pre-eclampsia and eclampsia. 
Substantiated further,  Khan, Wojdyla, Say, Gulmezoglu and Van Look (2006:1066),  identified in 
their studies that hypertensive disorders is the major contributor to maternal deaths. They 
emphasised that the reduction of maternal death is a high priority for the international community, 
especially in view of the increased attention on the Millennium Development Goals. Their study 
also confirms that hypertensive disorders during pregnancy are among the leading causes of death 
with a rate of 9.1% in Africa. 
2.3 TYPES OF HYPERTENSIVE DISORDERS IN PREGNANCY    
2.3.1 Ges ta tiona l hypertens ion and  chronic  hypertens ion 
Blood pressure ≥140/90 mmHg after or before 20 weeks of gestation on two occasions ≥6 hours 
apart. According to Leeners, Neumaier-Wager, Kuse, Irawan, Imthurn and Rath, (2005:442),as 
well as Lowdermilk and Perry, (2007:787). 
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2.3.2 Pre -ec lamps ia   
Pre-eclampsia is defined as gestational hypertension or chronic hypertension with second degree 
proteinuria ,≥ 0,3g/L in 24 hour urine specimen or dipstick proteinuria score ≥+ in random urine 
collection (Leeners, Neumaier-Wager , Kuse, Irawan, Imthurn and Rath, 2005:442). These findings 
are in line with the findings of Emery (2005:346), Coleman (2001:17), Molvarec, Prohaszka, Nagy, 
Szalay, Fust, Karadi and Rigo (2006:780); Florio, Torricelli, De Falco, Leucci, Giovannelli, Gazzolo, 
Severi, Bagnoli, Leoncini, Linton, and Petraglia  (2006:1831). 
2.3.3 Ec lamps ia 
Emery (2005:346), defined eclampsia as a new onset of grand-mal seizures in a woman with pre-
eclampsia, and is supported by Frishman et al. (2005:274), Peters and Flack (2003:209), Sellers 
(1997:1162), Zhang, Meikle and Trumble (2003:211). 
2.3.4  Pregnanc y induced  hypertens ion  
Pregnancy induced hypertension is defined as an  increase in diastolic blood pressure of 20 mmHg 
or more from that recorded at the first antenatal visit, on at least two occasions during the course of 
pregnancy (Ellison, De Wet, Matshidze &  Cooper 2000:77). This definition is supported by Peters 
and Flack (2003:209), Dafallah, El-Agib and Bushra (2003:369) and Roberts, Algert, Morris, Ford 
and Henderson-Smart (2005:333). 
2.4 FACTORS CONTRIBUTING TO HYPERTENSIVE DISORDERS IN PREGNANCY 
Various factors that contribute to the development of hypertensive disorders during pregnancy as 
described by various authors:  
2.4.1 Gravity a nd  pa rity  
It has been identified that the primigravida has a higher risk of developing a hypertensive disorder 
than the multiparous pregnant woman(Sellers, 2005:1172). 
The longer a woman lives with the partner or father of the baby before becoming pregnant, the 
lower the risk of developing a hypertension disorder due to lower levels of stress. Furthermore, the 
risk is also increased in multiparous women who become pregnant by a new partner (Emery, 
2005:347). These findings are aligned with the findings of Thelma and James (1999:17), Cundy, 
Slee, Gamble and Neale (2001:482). 
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2.4.2 Med ica l Cond itions  
According to Andreasen, Andersen and Schantz (2004:1023), obesity increases the risk of 
pregnancy induced hypertension, which is substantiated by the findings of Thelma and James 
(1999:17) and Cundy et al. (2001:482).  In addition they also referred to other medical conditions 
which contribute to the development of a hypertensive disorders in pregnancy such as renal, 
previous or existing hypertension, type 2 diabetes, family history, trophoblastic disease and 
hydrops fetalis. 
It was also identified that women who have had a previously growth restricted baby are more likely 
to develop pre-eclampsia, including women with mildly impaired glucose tolerance, not requiring 
treatment are also at increased risk of developing hypertension in pregnancy (Myers & Baker, 
2002:120). 
2.4.3 Demographic  Da ta 
2.4.3.1 Race 
Black women were shown to be at a substantially higher risk for developing pre-eclampsia versus 
women of other races, these findings are supported by Cundy et al, (2001:482).  
2.4.3.2 Socio-economic level 
Yucesoy, Ozkan, Bodur, Tan and Caliskan, (2005:349),  state that those of low socio economic 
status, especially the young women, are at risk of developing pre- eclampsia. Their study revealed 
that most of these women had no regular antenatal visits and were of low socio economic status 
and from rural regions. However, a study done by Wolf et ali (2004:334), opposed the statement by 
Mugo, et al (2005:349), that low socio-economic status is a risk factor in developing hypertensive 
disorders. Their study states that there is no evidence that low socio-economic status or insufficient 
access to prenatal care affected risk of disease.  
2.4.3.3 Life style  
According to Leeners, Neumaier-Wagner, Kuse and Rath (2006:1217), smoking contributes to the 
development of a hypertensive disorder. This statement is supported by Cundy et al. (2001:482), 
Sellers (1997:1163) and Emery (2005:346). 
2.4.3.4 Stress 
Stress resulting from home duties are shown to be a significant independent risk factor for 
pregnancy hypertension and superimposed pre-eclampsia, including being unemployed . This is in 
30 
 
 
contrast with some studies that suggest that , physical and psychological work stress could 
represent a risk factor (Heard,  Dekker,Chan,Jacob, Vreeburg&, Priest 2004: 42). 
According to Yucesory et al. (2005: 47), women living in rural regions experience their first 
convulsions mostly at home due to the lack of community health education.  
2.4.3.5 Late Admission to Health Facilities  
Late admission to health facilities and improper anticonvulsive prophylaxis could result in 
intracranial bleeding, septic shock and cardiopulmonary arrest as shown in a study by Yocesory et 
al. (2005: 47).   
2.5 PATHOPHYSIOLOGY 
Peters and Flack (2003:212), describe the pathophysiology of pre-eclampsia in two stages:  
2.5.1 Alte ra tion in  p lacenta l pe rfus ion  
Pre-eclampsia begins with placental changes. Normally the endovascular trophoblast cell of the 
placenta is supported to transform spiral arteries in the uterus to accommodate increased blood 
flow. In pre-eclampsia the arterial transformation is incomplete and women with the condition have 
a distinctive lesion terminal acute atherosclerosis, as well as a greater degree of placental 
infarction than is seen in normotensive gravidas, both of which can lead to decreased placental 
perfusion and placental hypoxia. 
2.5.2 Mate rna l s yndrome 
The maternal syndrome begins when the plasma volume is reduced as compared to normal 
pregnancy with decreased blood flow to organs other than the placenta resulting in 
haemoconcentration, haemorrhage and causing necrotic changes in the kidneys, including swelling 
of the glomerular endothelial cell cytoplasm. This causes a glomerular endotheliosis which 
correlates with proteinuria. Both the renal blood flow and glomerular filtration rate are decreased in 
pre-eclampsia. Uric acid clearance and renal calcium are affected, resulting in hypoglycaemia and 
elevated serum urate levels.  
Liver damage may be mild with elevated serum enzymes. There is an increase in microvascular fat 
deposition within the liver, which directly correlates with plasma uric acid levels and inversely 
correlates with platelet counts. Expansion of the liver parenchyma secondary to fat deposition is 
postulated as one cause of epigastric pain seen in severe pre-eclampsia. 
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Convulsions indicate that the central nervous system is involved, which results in seizures due to 
hypertensive encephalopathy. Vasoconstriction causes widespread microvascular cerebral 
changes and ischaemia may result in seizures.  All current literature by Mugo,et al (2005:349), 
Emery (2005:347), Thelma and James (1999:17), Frishman, Schlocker, Awad and Tejani 
(2005,:275),as well as  Duley (2003:163), support the above findings. 
2.6 CLINICAL MANIFESTATIONS  
2.6.1  Blood  p res s ure   
A study done by Peters and Flack (2003:213), indicates that clinical manifestations differ 
depending on the severity of the condition. They described mild pre-eclampsia as a mild elevation 
in blood pressure systolic, ≥140mmHg or diastolic ≥90. Frishman  et al (2005:275) , agree that 
severe pre-eclampsia is manifested by elevated blood pressure of systolic ≥160mmHg or diastolic 
≥ 110mmHg.  
2.6.2 Blood  te s ts   
According to the study by Peters et al. (2003:213), increasing serum creatinine (>2mg/dL), rapid 
increase in platelet count (<100,000/mm) and or evidence of microangiopathic hemolytic anaemia, 
with increased lactic acid dehydrogenase indicate severe pre-eclampsia. This is substantiated by 
the findings of Emery (2005:348). 
 2.6.3 Urina lys is   
Both Coleman (2001:17) and Peters et al. (2003:213), agree that proteinuria is a sign of 
hypertension when excretion is more than 3mg/24 hours or 2+ of protein in the urine.  
Mugo et al. (2005:349), differs in the finding of proteinuria in mild pre-eclampsia with proteinuria of 
≥300mg/24 hours. If 24 hour urine testing is unavailable, at least two random urine samples of at 
least 1+ (30mg/dL)  protein on urine dipstick, collected 6 hours apart (Cundy et al. 2001:483),as 
well as Mugo et al. (2005:349). 
2.6.4 Other c linica l manifes ta tions   
Other clinical manifestations reported are headache, visual changes, persistent epigastric pain, 
intra uterine growth restriction or oligohydramnios (Mugo et al, 2005:349).   
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Oedema of the face and hands, rapid weight gain and decreasd fetal movement are clinical 
manifestations for pre-eclampsia (Emery, 2005:348; Sellers, 1997:1165). 
High levels of soluble Fms-like tyrosine kinase 1, an anti-angiogenic protein that is associated with 
low levels of placental growth factor, an angiogenic protein have been shown to be early predictors 
of subsequent development of pre-eclampsia (Mugo et al, 2005:350). 
2.7 ASSESSMENT OF A PREGNANT WOMAN WITH A HYPERTENSIVE DISORDER 
2.7.1 Sub jec tive  Da ta : Inte rview 
An adequate medical history taking is essential which includes the review for especially the 
presence of diabetes mellitus, renal diseases and hypertension. 
Family, previous medical and obstetric history, operations, accidents and convulsions are  explored 
for hypertensive disorders, diabetes mellitus and other chronic conditions related to the 
development of hypertensive disorders.   
Social history should include a review of the woman’s marital status, nutritional status, cultural 
beliefs, activity level, and life style behaviours such as smoking, alcohol and drug use.  Any 
complaints of feeling very ill, severe frontal headache, visual disturbances, nausea and vomiting 
and epigastric pain should be taken note of (Lowdermilk & Perry, 2007:790). 
2.7.2 Ob jec tive  da ta: Phys ica l examina tion. 
The physical examination will not only include the mother but the fetus as well 
2.7.2.1 Physical assessment of the fetus  
According to Fraser, Cooper and Nolte (2003:342), fetal assessment is done by the use of the 
following kick charts, CTG monitoring, serial ultrasound scans, assessment of amniotic volume and 
fetal breathing movements. These findings are in line with the findings  of Cronje and Grobler 
(2006:506). 
a. Monitoring of the Fetus 
According to Sellers (1997:1172) the fetal heart should be checked and recorded 4 hourly. Any 
deviation from the normal which is 100-160 beats per minutes must be reported to the doctors. 
Fetal movement should be monitored by giving the woman a fetal wellbeing chart to record the 
kicks of the fetus. The amount of amniotic fluid present can be assessed by ultrasound. If amniotic 
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fluid is less than normal the fetus is in danger. Auscultation of the fetal heart for the presence of 
fetal heart beat and for any irregularity is vital.  
The fetal heart rate can be assessed intermittently by means of a manual  stethoscope or hand 
held doppler device or it may be assessed continuously using electronic fetal monitoring (EFM). 
The fetal heart rate should be taken over a complete minute, in order to listen for the beat-to-beat 
variation. The baseline should be between 110 and 160 beats per minute.  
The midwife may use a Pinard stethoscope to listen to the fetal heart rate as the contraction is 
finishing, detecting any slow recovery of the fetal heart rate back to the baseline. Normally the 
baseline is maintained during the contraction and immediately after it. If decelerations are heard 
with a Pinard  stethoscope or Doppler instrument in the first stage of labour, then electronic 
monitoring may be indicated to assess the extent of decelerations (Nolte, 2008:19). 
2.7.2.2 Physical Assessment of the Mother 
a. Measuring of blood pressure 
For a pregnant woman a systolic blood pressure of 120 mmHg and diastolic blood pressure of 
80mmHg is regarded as normal blood pressure (Sellers, 1997:1164). Pre-eclampsia is indicated 
when the blood pressure is raised to 140/90 mmHg or more, taken after 10 minutes of resting. 
Blood pressure may be taken with the patient sitting, but if raised it must be confirmed with a 
patient lying down after 2-3 minutes of  rest (Huggins, 2001:2) and  Tr anqiulli, Giannubilo, 
Dell’Uomo and Corradetti, 2004:5). (Wallenburg, 2000:1).  
Monitoring of blood pressure for an hour is objective and reduces the risk of faulty and diagnostic 
pitfalls  
A study by Benette  and  Brown (1999:15), state that blood pressure should not be taken after the 
woman had been  experiencing anxiety or pain, had been exercising or smoking, because the 
readings will be incorrect.  
Further more,a study done by Peters and Flack (2003:210), revealed that blood pressure 
measurements are subjected to a variety of errors arising from the patient,  the person taking the 
measurement and or the environment. To reduce these errors a 24-hour ambulatory monitoring 
may be used. Ambulatory methods give an average blood pressure reading for 24 hours, as 
determined by multiple readings taken during the patient’s normal home and work routine. 
National Maternity Care Guidelines Committee of the Department of Health  (2007:78), advise that 
the midwife must take the diastolic pressure at the point where the sounds disappear (Korotkoff 
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phase 5), in patients where sounds do not disappear, use the point of muffing (Korotkoff phase 4). 
This is supported by Lowdermilk and Perry (2007:790).   
b. Urine Testing 
A normal test result for proteinuria is 10-100mg/24 hours. According to Gibson (2006:20) a 24 hour 
urine collection for protein excretion in pregnant woman which is up to 300 mg/d and higher are 
abnormal and may reflect renal involvement during pre-eclampsia. Urine should be checked using 
a urine dipstick. The urine volume total protein and creatinine should also be measured.  
In a study of 12 and 24 urine samples the total protein values correlate well for the diagnosis of 
pre-eclampsia.  In addition in a study of 15 patients for a 24 hour urine specimen, the results show 
60% with significant proteinuria. This fin (ding is supported by Wallenburg (2000:1), Bennette and 
Brown (1999:15), Nolte (1998:278) and Sellers 1997:1169). 
According to De Swiet (1998:537), proteinuria is usually the last sign of pre-eclampsia to be 
manifested and is always serious. Protein may also be found in urine which is contaminated by 
vaginal discharge due to infection, urinary tract infection and amniotic fluid or blood.  Therefore, if a 
midstream specimen looks crystal – clear but contains protein it is a true proteinuria, and is an 
indication that the kidneys are damaged and plasma proteins are leaking from the blood into the 
urine.  
c. Assessment of renal function, thrombocytopenia and liver enzymes are essential to 
diagnose hypertension during pregnancy. 
Oedema and Excessive Weight Gain 
Sudden, severe, widespread appearance of oedema is suggestive of pre-eclampsia. The oedema 
pits on pressure and may be found in non-dependent anatomical areas such as the face, hands, 
lower abdomen, vulva and sacral areas (Fraser, Cooper & Nolte 2003:341 and  Cronje and 
Grobler, 2006:499). 
Overweight and weight gain between pregnancies are associated with recurrent hypertensive 
disorders in pregnancy in a woman with gestational hypertension (Hjartardottir, Leifsson, Geirsson 
and Steinthorsdottir, 2006:917). 
Lowdermilk and Perry (2007:790), suggest that the following information should  be obtained: 
• dependent oedema should be assessed on the dependent parts of the body where the 
hydrostatic pressure is the greatest. It can be observed on the feet and ankles in 
ambulatory patients. In a pregnancy it is observed in the sacral region. 
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• pitting oedema that leaves a small depression after the finger is applied to the swollen area 
and disappears within 10-30 seconds. 
• deep tendon reflexes should be examined to determine any changes. 
2.7.3 Diagnos tic  te s ts   
2.7.3.1 Laboratory tests 
The blood and urine tests as discussed in paragraphs 2.5.2, 2.5.3 and 2.6.2.2 are recommended. 
2.7.3.2 Amniocentesis 
An amniocentesis can play a vital role in assessing lung maturity in deciding whether to deliver the 
baby (Emery, 2005:349 and Peters   et al., 2003:214). 
2.8 MANAGEMENT OF HYPERTENSIVE DISORDERS IN PRIMARY HEALTH CARE 
Hypertensive disorders  may affect all the systems  of the  body,  which may result in the woman 
being  exposed  to  many injuries and fears, deficient  diversional  activity,  irritability  of  the 
nervous  system, and  is  at risk for excess fluid  volume,  related  to increased  sodium and a 
decreased  cardiac output (Lowdermilk & Perry, 2007:795). 
2.8.1 Nurs ing  Care  
Registered  midwives  should  review  the  warning  signs or symptoms  of pre-eclampsia  to  
ensure  that an adequate  knowledge base  exists for decision  making, Signs and  symptoms such 
as frontal headache, epigastric pain and blurred vision.   
Lowdermilk and Perry(2007:795), suggest the following:  
2.8.1.1 Home-Based Care 
a. Home environment 
The home environment should include the woman’s ability to assume self-care responsibility.  
b. Self Care 
The  woman should be taught how  to  do  a self-assessment  for  clinical  signs of  pre-eclampsia 
to  provide  immediate  evidence  of  a  worsening  condition.  
c. Diet 
The diet should be high in protein, a high vitamin intake, low in carbohydrates and no extra salt.  
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Her intake should include the required amount of protein and vitamins to nourish her growing fetus 
and to prepare her body for lactation. If the patient has oedema, sodium chloride can be used for 
cooking. 
d. Weight gain 
The patient should monitor her weight, by monitoring the swelling of her feet and hands, and 
puffiness around the eyes. She should also try to lose weight if obese. 
e. Monitoring blood pressure 
Blood pressure of the patient should be monitored accurately at each weekly clinic visit from 20 
weeks of gestation until delivery. 
f. Urine testing 
Patients should be taught to test their urine for protein. 
2 + proteinuria, weight  gain and decreased  fetal activity  should be reported to her health  care  
provider  immediately to  prevent  worsening  of a pre-eclampsia  condition.  
g. Bed rest 
Teach the pregnant woman about the use of rest and relaxation as palliative treatment options to 
decrease blood pressure and promote diuresis. The patient should have adequate bed rest (12 
hours at night and a further 3 hours during the day, to ensure an improved blood flow to the heart 
and to the placenta.  
h. Stress management 
Stress management and relaxation techniques to help manage tension of confinement should be 
taught to the pregnant woman. 
i. Family support 
The  midwife  should  provide  a  calm, soothing atmosphere and teach  the family to  provide  
emotional support  to  facilitate  coping. Encourage verbalization of fears to decrease intensity of 
emotional response. Promote family  participation in  the  management of  her  pre-eclamptic  
condition,  to  promote  a  greater  sense  of  control. Assist the woman to be creative and explore 
personally meaningful activities.   
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2.8.1.2 Antenatal Care in Primary Health Care  
The role of the midwife in the primary health clinic is critical in preventing, identifying and managing 
hypertension disorders. In the event that pre-eclampsia is diagnosed the patient is immediately 
referred to an obstetrician (Fraser &  Cooper, 2009:403). 
The following nursing interventions are suggested and should be adhered to:  
a. Patient’s History (See also paragraph 2.6.1) 
Fraser and Cooper (2009: 402-404), suggest the following specific antenatal interventions: 
• the accurate measuring of blood pressure is essential in the management of hypertensive 
disorders.  
• daily blood pressure measurements are required if it is not elevated or where signs  of 
hypertension are absent. 
b. Urinalysis  
Urine is tested for proteinuria. If the  midwife  identifies  protein  in the  midstream  specimen  of  
urine, a 24 hour urine  collection  is  required, in  order  to  determine  the  amount  of  proteinuria. 
c. Oedema   
A physical examination is done for signs of oedema. Special observations should be made of 
oedema on the lower extremities of the body. Oedema may first  be evident in the feet and ankles. 
d. Fetal monitoring  
Auscultation  of  the fetal  heart  for  the  presence  of the  fetal  heart  beat  and  for  any  
irregularity  which  may  indicate  fetal  distress should be done. The fetal  movement  chart  and a  
biophysical  profile to  assess  the  fetal  health  and  well-being should be implemented. The  
patient  is  instructed  on  how  to  carry  out the  kick  count  test. 
e. Abdominal examination   
The abdomen is  observed  for  clinical  signs  of  reduced  amniotic fluid and  fetal  growth  
retardation. Any discomfort or tenderness should be recorded and  reported to the doctor. 
f. Primary health care clinic visits 
Sellers (1997:1172), supported by various researchers in obstetrics such as Coleman (2001:17), 
Emery (2005:348), Peters et al. (2003:213) and Duley (2003:167) recommend that weekly 
antenatal visits to the primary health care clinic are essential to prevent further deterioration of the 
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condition. The patient is also informed to visit the clinic or hospital if there is any swelling of the 
legs or fingers or a decrease in fetal movement.  
g. Additional interventions by the primary health care midwife 
The midwife assesses the fetal condition. However, in the event where a doctor is available in the 
clinic or hospital, a fetal non-stress test and ultrasonic scan for signs of intra uterine growth 
retardation, is prescribed. The patient is usually admitted to the hospital at about 37 weeks 
gestation, if the condition is stable.  
Intravenous fluids may be given in the clinic as prescribed but, care should be taken that the 
patient is not over-hydrated, especially where there is reduced fluid output. Furthermore, the 
midwife must check for any signs of labour. Facilities should be available in the clinic to manage an 
eclamptic fit (Sellers, 1997:1171-1173). These interventions are supported by the National 
Maternity Care Guidelines Committee of the Department of Health  (2007:81-83), Peters et al. 
(2003:214)and Mugo et al. (2005:352).  
h. Medical treatment in the prevention of hypertensive disorders 
The  midwife  should  ensure that  calcium supplements  are prescribed to  reduce  the  risk  of  
hypertensive  disorders. A diet rich in protein, fibre  and vitamins are recommended. The use of  
antioxidants, vitamin C  and  E  supplements  are also  recommended  to  reduce  the  risk  of  pre-
eclampsia. These  supplements  do  not  prevent  pre-eclampsia in  the  women  at  risk for a 
hypertensive disorder, but will have an adverse effect on the baby by increasing  the  rate  of  
babies  of  low  birth  weight. (Fraser & Cooper 2009, 403-405). 
It has been shown in a study of 100 high risk women, treated with aspirin that  preterm deliveries 
are prevented by improving the blood to the kidneys, brain and uterus (Fraser &  Cooper 
2009:404). 
i. Medical treatment for hypertensive disorders 
The use of anti-hypertensive therapy as prophylaxis shows no benefit in significantly prolonging 
pregnancy or improving maternal or fetal outcome. Its use is however advocated as short term 
therapy in order to prevent an increase in blood pressure and the development of severe 
hypertension; thereby reducing the risk of cerebral haemorrhage  (Fraser & Cooper, 2009:404).  
Methyldopa (Aldomet), is the most widely used anti-hypertensive medication  in women with mild to 
moderate gestational hypertension and appears to be safe and effective for both mother and fetus. 
Nifedipine (Adalat), is being used increasingly to treat severe hypertension in pregnancy although 
its safety and efficacy are still to be evaluated. It improves cardiac output when peripheral 
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resistance is reduced. It has also been found that the use of anti-coagulants or anti-platelet agents 
have been considered for the prevention of fetal growth restriction and pre-eclampsia. Aspirin is 
commonly used to inhibit the production of the platelet-aggregating agent, thromboxane A2 
(Lowdermilk & Perry, 2007:1146).  
Emery (2005:348), states that magnesium sulfate is still the drug of choice for preventing and 
arresting eclamptic seizures.  
Diazepam (valium), is given to promote patient sleep and to lower the diastolic blood pressure to 
below 100 mmHg; it is also recommended that hydralazine is used to lower the blood pressure. 
Continuous monitoring of the blood pressure is required to determine whether the treatment is 
effective.  If the patient does not respond to the treatment the primary health care midwife should 
refer the patient to the hospital for further management (Sellers, 1997:1182). 
2.9 COMPLICATIONS OF HYPERTENSIVE DISORDERS  
2.9.1 Fe ta l g rowth res tric tion  
Intra uterine growth restriction is defined as a birth weight of less than the 5th percentile, as 
currently guided by the National Maternity Care Guidelines Committee of the Department of Health 
(2007:91). Intra uterine growth restriction (IUGR), is reflected by small for gestational age. The 
status is considered a measure of severity of hypertensive disorders of pregnancy due to utero-
placental insufficiency before 20 weeks of gestation 
According to the study of Grisaru-Granovsky, Halevy, Eidelman, Elstein and Samueloff (2007; 
335), it was identified in a study of 30 woman, that 16% presented with  intrauterine growth 
restriction during pregnancy, preceding the diagnosis of hypertensive disorders of pregnancy.  
The National Maternity Care Guidelines Committee of the Department  of Health(2007:91), state 
that intra uterine growth restriction is associated with placental insufficiency which may result from 
pre-eclampsia. A physical examination shows the following clinical manifestations: 
• On palpation the fetal head is hard with a small body  
• The head engages before 37 weeks  
• Reduced amniotic volume  
• Irritable uterus before 37 weeks 
• A measurement less than the 10th centile for gestational age  
• Failure of the  symphysis  fundal  height to increase.   
40 
 
 
These serial measurements should raise suspension of IUGR in the mother with hypertensive 
disorders.  
Thelma and James (1999:17), mentioned that there is an expected fetal response of lowered 
weight gain in women with hypertensive disorders. Their findings shows that 30% of infants for pre-
eclamptic  women are growth restricted.  
2.9.2 Complica tions  o f the  mother    
2.9.2.1 Abruptio Placenta 
After the 22nd week of pregnancy premature separation of a normal positioned placenta occurs. 
The cause is often associated with severe pre-eclampsia due to placental dysfunction. Partial 
separation of the placenta causes bleeding from the maternal venous sinuses in the placental bed. 
Further bleeding continues to separate the placenta to a greater or lesser degree. There is no 
vaginal bleeding, but the mother will have all the signs and symptoms of hypovolaemic shock, 
caused by concealed bleeding into the muscle of the uterus (Sellers, 2006:1196).  
The fetus is directly affected by the abruptio placenta and fetal monitoring with the use of a 
cardiotocograph will provide complete information about the fetal condition. The midwife should be 
vigilant in how information about the fetus is conveyed to the mother. If the fetal heart is absent on 
the first examination, she should explain to the mother that a fetal monitor is needed to establish 
the condition of the baby. The woman should be transferred to a consultant obstetric unit. The 
midwife may site an intravenous cannula prior to transfer (Nolte, 1998:283-285).  
2.9.2.2 Acute Renal Failure 
Pre-eclampsia causes a reduced blood supply to the kidneys, resulting in oliguria.i.e. a urinary 
output < 400mls in 24 hours. The tubules and glomeruli have become ischaemic and if prolonged 
degenerative changes in the epithelium of the tubules occurs (Sellers, 1997:1632-1633). 
Consequently, it will result in renal cortical necrosis of the tubules that may result in acute renal 
failure that warrants a referral to the dialysis unit (Smeltzer & Bare, 2000:1148-9). 
a. Clinical manifestations will include : 
• dry mucous membrane  
• breath may have an odour of urine “urinic fetor” 
•  headache  
• persistent vomiting  
• diarrhoea 
• tachycardia  
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• affected central nervous system will result in drowsiness, headaches and seizures  
• laboratory tests may show increase  in serum urea, creatinine and nitrogen. 
. 
Interventions include accurate fluid intake and output and a diet low in protein. Reduce fluids to 
500-1000ml daily (Sellers, 1997:1632-1633 and Nolte, 1998:348). 
2.9.2.3 HELLP Syndrome (Haemolysis, elevated liver enzymes and low platelet count) 
The HELLP syndrome is thought to be a multiple systemic component of the syndrome of a severe 
pre-eclampsia due to endothelial injury.  
a. Clinical manifestations may include: 
• flu-like symptoms 
• right upper quadrant pain  
• nausea  
• vomiting 
• mucosal bleeding  
• petechial haemorrhages  
• presence of micro-angiopathic haemolytic anaemia  
• elevated lactate dehydrogenase levels  
• significant drop in haemoglobin.  
According to Emery (2005:347), these clinical manifestations may be suggestive of HELLP 
syndrome, substantiated by Mugo et al. (2005:352), Sellers (1997:1167), Nolte (1998:291) and  
Fraser et al. (2003:365).  
Emergency care will be determined by the severity of the maternal condition and the maturity and 
well being of the fetus. Pregnancy will be terminated or the woman will be relieved by the delivery 
of the baby at 34 weeks gestation when the lungs are  fully matured or when the  fetus is at danger 
during an eclamptic period of the mother (Nolte, 1998:293  and Leerners, Rath, Kuse and 
Neumaier-Wagener,2005:556). 
2.10 CONCLUSION 
This chapter described an intensive literature review about hypertensive disorders in pregnancy. 
The following aspects were addressed: the types of hypertensive disorders, factors contributing to 
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hypertensive disorders, pathophysiology, clinical manifestations, assessment, diagnosis and the 
management of hypertensive disorders and complications.  
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CHAP TER 3: RESEARCH METHODOLOGY 
3.1  INTRODUCTION  
The impetus of this chapter is to describe the research methodology that was applied to determine 
the knowledge of registered midwives managing hypertensive disorders in pregnancy at primary 
health care Level in the Buffalo City Local Service Area of the Eastern Cape Province.  
3.2  GOAL 
According to Burns and Grove(2007:99),a research purpose is  a  clear  concise statement of the 
specific aim or goal of the study. 
The purpose of this study was to investigate scientifically the knowledge of the registered midwives 
managing hypertensive disorders in pregnancy working in the Primary Health Care Services in the 
Buffalo City Local Service Area of the Eastern Cape Province.  
3.3  OBJ ECTIVES 
The objectives for this study were to determine whether the registered midwives working in primary 
health care facilities have adequate knowledge about:: 
• hypertensive disorders in pregnancy 
• the assessment of hypertensive disorders in pregnancy  
• the diagnosis of hypertensive disorders in pregnancy  
• the management of hypertensive disorders in pregnancy. 
3.4  RESEARCH METHODOLOGY 
3.4.1  Res ea rch des ign 
An explorative, correlation, non-experimental research design was applied with a quantitative 
approach, to investigate scientifically the knowledge of the registered midwives about hypertensive 
disorders in pregnancy working at primary health care level in the Eastern Cape Province.   
According to De Vos, Strydom, Fouche and Delport (2002:143), the aim of exploratory research is 
to explore a relatively unknown research area. The purpose is to gain a new insight into the 
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phenomena under study, rather than collecting accurate and replicable data. During this study the 
researcher explored the literature and the natural setting of registered midwives and their 
experiences with the management of hypertension at primaryealth care level. This was done to 
extend the theoretical knowledge base about the registered midwives and their practices. 
3.4.2  Res ea rch ques tion  
A research question is a concise interrogative statement, developed to direct studies that are 
focused on the description of variables or the examination of relationships between variables and 
the prediction of dependent variables, using independent variables (Burns &Grove, 2007:720). The 
research question which guided this study was: “Do the registered midwives working at primary 
health care level have adequate knowledge about the management of hypertensive disorders in 
pregnancy?” 
3.4.3  Popula tion and  s ampling 
According to LoBiondo-Wood and Haber (2006:569), a population is a well defined set that has 
certain specified properties.  It is furthermore described as a collection of objects, events or 
individuals having some common characteristics that the researcher is interested in studying 
(Mouton, 1996:134). The population target group for this study was the registered midwives 
working in the primary health care Clinics in the Buffalo City Local Service Area of the Eastern 
Cape The total population of registered midwives working in this particular area was 228.  
Sampling is a process in which representative units of a population are selected for study in a 
research investigation (LoBionda-Wood and Haber: 2006:572). 
As shown in table 3.1 Region C in the Eastern Cape consists of 98 clinics which include rural and 
urban clinics in the Buffalo City Local Service Area. A random sample of 43 (44%) clinics was 
drawn from the total number of  98 clinics. The researcher used 28 (42%) clinics from the rural 
area and 15 (47%) clinics from the urban area. A stratified random sample was applied to draw the 
list of all clinics and select every second clinic on the list. The target population for this study was 
the registered midwives allocated in these clinics. In the rural clinics 2 registered midwives (RM) 
were allocated and in urban clinics 3 registered midwives were allocated per clinic. The total 
population of the registered midwives working in the Buffalo City Local Service Area was 228.  A 
stratified random sample was applied to select the sample of registered midwives, 101 (44%) of 
the total population of 228 as planned and shown in tables 1.2 and 1.3.  Guided by the statistician 
a sample of at least 100 registered midwives were required, because it improves the validity of the 
study..    
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3.4.4  Crite ria  
The criteria used in a study refer to those characteristics that a subject or elements should possess 
to be part of the target population (Burns & Grove, 2007:345). 
3.4.4.1 Inclusion criteria  
The following subject selection criteria were set for the purpose of this study: 
• all registered midwives working in the clinics of Buffalo City Local Service Area 
• all midwives permanently employed at one of the participating clinics. 
3.4.4.2 Exclusion Criteria 
This study excluded all other nursing categories namely:  
• enrolled nurses 
• enrolled nursing assistance. 
3.4.5  Pilo t Study 
A pilot study attempts to test the instrument for ambiguity and accuracy and is a trial run done in 
preparation for a major study (Polit & Hungler, 2001:467). According to LoBiando-Wood and Haber 
(2006:569), it is a smaller version of the actual study conducted as a prelude to a larger scale 
study, but is often called the “parent study”. 
A pilot study was conducted in four primary health care clinics in April 2009 to determine the 
feasibility of the actual study. A stratified sample of 11 (10%), was randomly selected based on the 
actual number of participants which formed the sample of the study. These participants did not 
form part of the actual study. The results of the pilot study showed that there was some ambiguity 
in the questions and these were addressed. The participants of the pilot study were excluded from 
the actual study.  
3.4.6  Re liab ility and  Va lid ity 
Reliability of a study represents the consistency of the measure obtained while validity is the 
measure of the truth or accuracy of a claim. This is an important aspect throughout the research 
process. Burns and Grove (2009:718, 727, 2007:552 and 559) also describe validity as an extent 
to which an instrument accurately reflects the abstract concept being examined. Supported further, 
validity is the extent to which an instrument measures what it is supposed to measure (Polit &  
Hungler, 2001:473).  
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For the purpose of this study content validity was assured through an extensive literature review, 
representatives of the relevant population and content experts.  Experts were consulted to assist 
with the appropriateness of the individual questions in the questionnaire, thus helping to establish 
content validity for the instrument.  A statistician was consulted with the design of the questionnaire 
and to assist with the planning of the data analysis and was also consulted throughout the study.  
At least 6 experts in midwifery and a research methodologist were consulted to evaluate the 
content validity of the instrument. The reliability and validity of the study was further assured by 
testing the instrument during a pilot study. All ambiguity and inaccuracies were addressed as 
identified in the pilot study, specifically related to the section on the management and prevention of 
hypertensive disorders.  Furthermore, the researcher collected all data personally.  
3.4.7  Ins trume nta tion 
According to Burns and Grove (2009:704), instruments are measuring tools which adhere to 
specific rules when being developed. LoBiondo-Wood and Haber (2006:565), refers to 
instrumentation as “…changes in the measurement of the variables that may account for changes 
in the obtained measurement…” 
The instrument developed for the purpose of this study was a structured questionnaire consisting 
of only closed questions. The design of the questionnaire was based on an extensive literature 
research and the researcher’s clinical experience.  
The questionnaire was validated by at least 6 experts in midwifery including a research 
methodologist and statistician.  
A self administered questionnaire was developed for registered midwives. It was divided into 4 
sections namely biographical, knowledge concerning questions on diagnosis, assessment and 
management of hypertensive disorders. The instrument was intended to elicit information through 
written responses from the participants (Annexure A).  
3.4.7.1 Layout of questionnaire: 
Section A: Biographical data 
Questions 1- 5  were based on the age, gender, basic qualifications and years of clinic experience. 
Questions 6-10 were based on the visit of the doctors to the clinic, average number of clients 
managed per day and the number of registered midwives working in the clinic.  
All these questions provided information about the strength of registered midwives working in the 
clinics. 
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Section B: Knowledge and diagnosis of hypertensive disorders in pregnancy. 
Questions 11-19  were based on  hypertensive disorders, associated risk factors and the effect of 
on the mother and  the fetus. Questions 11, 12, 13, 15, 16, were based on the diagnosis of a 
hypertensive disorder.   
Section C: Assessment of hypertensive disorders in a pregnant women.  
Questions 20-37 were based on the assessment of the medical and social history, physical 
examination, clinical manifestations and diagnostic tests.  
Section D: Management of hypertensive disorders in pregnancy. 
Questions 38-45 were based on the management of hypertensive disorders: including prevention 
and treatment.  
3.4.8 Da ta  Co llec tion 
According to Burns and Grove (2007:536), data collection is the systematic gathering of 
information relevant to the research papers or specific objectives, questions or hypothesis. The 
researcher obtained  consent  from the participants and maintained  confidentiality  with all the 
information.  
For the purpose of this study the researcher collected all data personally by handing out a 
structured questionnaire to individual participants and collecting it in a sealed envelope after 
completion.   
Data collection was done over a period of 4 weeks during May 2009.2. A 100% return rate was 
achieved. The questionnaire was completed within 30 minutes.  
3.4.9 Da ta  ana lys is  and  inte rp re tation 
The data was analysed and interpreted by the researcher with the help of a statistician and a 
computer program, the STATISTICA (Version 8). The data was tabulated and presented in graphs, 
tables and frequencies. Statistical associations were determined between various variables using 
various statistical tests to test for associations between variables. Further discussion is to be found 
in chapter 4. 
3.5  LIMITATION OF THE STUDY 
The study was executed as planned with no limitations.  
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3.6  ETHICAL CONSIDERATION 
The researcher obtained consent to conduct research from the committee for Human Science 
Research of the Faculty of Health Sciences, Stellenbosch University, as well as the Head of 
Department of Health in the Eastern Cape Province(Annexure C) where the research was 
conducted (Annexure B ). Informed written consent was obtained from the participants (Annexure 
D). Confidentiality and privacy concerning all information were ensured. To ensure anonymity each 
participant was provided with a questionnaire and an envelope. Participants were advised to place 
the questionnaire into the envelope provided after completion. Sealed envelopes were handed 
directly to the researcher. The individual data has been stored and is only accessible to the 
researcher. It will be kept for a period of five years, thereafter it will be destroyed. 
3.7 CONCLUSION  
In chapter 3, the researcher described the research methodology related to the project. The 
different steps of the methodology and limitations concerned with the project were described. The 
procedures involving data analysis and interpretation are discussed in chapter 4. 
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CHAP TER 4: ANALYSIS  AND INTERPRETATION OF 
RESEARCH FINDINGS 
4.1  INTRODUCTION 
In this chapter, the findings of the research study titled “Evaluation of the knowledge of the 
registered midwives working in primary health care in the Eastern Cape” will be presented and 
interpreted. A quantitative approach was applied.  
4 .2  DESCRIPTION OF STATISTICAL ANALYSIS 
The data are presented in the form of frequency distribution tables, a graphical presentation and 
frequencies. The  chi-squared, Mann Whitney, Kruskal Wallis  and Spearman  statistical correlation 
tests  were  used  to  test  for  associations  between  demographic   variables   and  the  
responses  to  the  questions   about  the  knowledge of  the  nurses   working   in  clinics  on 
hypertensive disorders. 
The  p – value  is  the  measure  reported  from  all  tests  of  statistical  significance. It is  defined  
as  the  probability  that  an  effect, at least  as  extreme  as  that  observed  in a  particular  study, 
could  have  occurred  by  chance  alone if  the  p – value  is  greater  than  0.05  by  convention, 
the  chance  cannot  be  excluded  as  a  likely  explanation   and  the  findings  are  stated  as  not  
statistically  significant  at  that level  (Burns  & Grove, 2007:328-331). Therefore  the  95%  
confidence  interval  was applied  to determine  whether  there  was  an  association  between  
variables.  
In addition the results are presented in mean scores based on the knowledge of the participants 
with reference to the questionnaire in totality and to the specific sections. 
4.3  SECTION A: BIOGRAPHICAL DATA 
4.3.1 Variab les  1-5: Age  g roup 
Table 4.1 shows that n= 67(66.3%), of the participants were older than 40 years of age while n=34 
(33.7%), were younger than 40 years of age.  
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Table 4.1: Age group 
Variables Age  n (%) 
1 21yrs-30yrs 10 (9.9%) 
2 >30Yrs-40yrs 24 (23.8%) 
3 >40yrs-50yrs 33 (32.7%) 
4 >50yrs 27 (26.7%) 
5 >60yrs 7 (6.9%) 
 TOTAL 101 (100%) 
4.3.2 Variab les  6-7: Gender 
Table 4.2 shows that n=88 (87.1%), of the participants were females. This distribution shows the 
dominance of females in the profession which is substantiated by Kelly (2006:27), who has 
acknowledged the female dominance in the nursing profession. A further analysis shows that there 
is no statistical significance between gender and knowledge according to the Man-Whitney 
statistical test (p=0.41). However, the males obtained a higher mean score (0.683), on the 
knowledge of hypertensive disorders than the females (0.663). The total mean score of all the 
participants were 0.666.  
Table 4.2: Gender n=101 
Variables Gender n (%)=101 
6 Male 13 (12.9%) 
7 Female 88 (87.1%) 
 TOTAL 101 (100%) 
4.3.3 Variab les  8-12: Qua lifica tions  in  midwife ry 
Table 4.3 shows that  the majority of participants in=53 (52.4%), indicated that they had a one year 
diploma in midwifery, followed by those with  the 4 year diploma in General Nursing (Psychiatry & 
Community Health) and Midwifery  n=33 (33.7%). Only one participant held an advanced diploma 
qualification in midwifery. A further analysis shows that there is no statistical significant association 
between qualifications (4 year diploma in nursing, degree in nursing and one year basic diploma in 
midwifery ) and their knowledge about hypertensive disorders. However, the mean scores of the 
knowledge about hypertensive disorders obtained between the three qualifications shows that the 
1 year basic diploma in midwifery  obtained the highest score as shown in figure 4.1.  
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Table 4.3: Qualifications in midwifery (n=101) 
Variables Qualifications n (%) 
8 4yrs Diploma in General Nursing 33 (32.7%) 
9 4yrs Degree in General Nursing 14 (13.9%) 
10 1yr Diploma in Midwifery 53 (52.4%) 
11 Advanced Diploma in Midwifery 1 (1.0%) 
12 Other 0 (0%) 
 TOTAL 101 (100%) 
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Figure 1: Qualifications and mean scores of three qualifications  
4.3.4 Variab les  13-17: Pe riod  of experience  as  midwife 
Table 4.4 shows that the majority of participants, n=41 (40.6%), have more than 10 years of 
experience in midwifery, followed by those with more than 6 months but up to 3 years, with n=22 
(21.8%).The least number of participants, n=5 (5%) had experience in midwifery ranging from 0 to 
6 months. Experienced midwives are therefore working in the clinics that formed part of this  study.  
Table 4.4: Period of experience as a midwife (n= 101) 
Variable Experience n (%) 
13 6 months or less 5 (5%) 
14 >6 months-3yrs 22 (21.8%) 
15 >3yrs-5yrs 15 (14.8%) 
16 >5yrs-10yrs 18 (17.8%) 
17 >10yrs 41 (40.6%) 
 TOTAL 101 (100%) 
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4.3.5 Variab les  18-22: Experience  as  a  midwife at the  p res ent c linic  
Table 4.5 indicates that the majority of the participants have more than 5yrs experience in 
midwifery, n=59 (58.4%), followed by participants with experience between 3yrs-5yrs, n=15 (4.8%). 
Only 5 (5%), have less than 6 months of experience. The clinics are well resourced in terms of 
experience in midwifery, which is an advantage to the clinical environment.   
Table 4.5: Period of experience as a midwife (n = 101) 
Variables Experience n (%) 
18 6 months or less 5 (5%) 
19 >6 months-3yrs 22 (21.8%) 
20 >3yrs-5yrs 15 (4.8%) 
21 >5yrs-10yrs 18 (17.8%) 
22 >10yrs 41 (40.6%) 
 TOTAL 101 (100%) 
4.3.6 Variab les  23-24:  Do  doc to rs  regula rly vis it the  c linic?  
Table 4.6 shows that n= 73 (72.3%), of the participants indicated that the doctors regularly visited 
their clinics for consultation with patients. Despite the fact that  
28(27.7%), indicated that they do not receive  any visits from doctors, this is in line with the Primary 
Health Care Policy  as described in the 2010 Service Plan of the Western Cape, that indicates that 
the primary health care nurse practitioner or advanced trained midwife will manage PHC clinics. 
However, only 1 (1%), of these participants held a  Diploma  in Advanced Midwifery, as shown in 
table 4.3. Problems may result in the clinical environment as a result of this deficit as sudden 
emergency high risk complicated deliveries such as forceps delivery may only be managed by 
advanced trained midwives 
Table 4.6: Do doctors regularly visit the clinic? (n=101) 
Variables Regular doctor’s visits to the 
clinics 
n (%) 
23 No 28 (27.7%) 
24 Yes 73 (72.3%) 
 TOTAL 101 (100%) 
A Man-Whitney statistical test shows a significant statistical association between the knowledge of 
staff in clinics where doctors are visiting regularly and where there are no visits (p=0.04). In clinics 
where there are no doctors’ visits the knowledge of the staff is higher (0.691), than the total 
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knowledge mean score (0.666). Where doctors are regularly visiting the clinics the mean 
knowledge score is lower (0.656), than the total knowledge mean. 
4.3.7 Variab les  25-28:  If “Yes ” How often?  
Table 4.7 proves that n=73 (72%), participants indicated that doctors do visit their various clinics. 
However, n=33 (45.2%), of them stated that the doctors pay a visit once a week, with n=28 
(38.3%), indicating that doctors usually visit once a month. 
Table 4.7: If “yes”, how often does the doctor visit the clinic? (n = 73) 
Variable If “yes”, how often do doctors visit the clinic? n (%) 
25 Daily 11 (15.1%) 
26 Once a week 33 (45.2%) 
27 Once a month 28 (38.3%) 
28 Other 1 (1.4%) 
 Total 73 (100%) 
4.3.8 Variab les  29-32:  If “No” Why?  
Table 4.8 shows that n=16 (57.1%), of those participants who indicated that there were no doctors’ 
visits indicated a shortage of doctors as a reason, while n= 7 (25%), indicated that the midwives 
were competent to do the job, n= 5(18%). Among the participants, n=5 (100%), who had other 
reasons, n=3 (60%), of them said their patients were always referred to hospital, n=1(20%), 
claimed that their organogram did not include doctors and the last one n=1(20%), said that there 
was no allocation for doctors. 
Table 4.8: If “no”, reasons for no visits (n=28) 
Variables If no, reasons for no doctor’s 
visits.  
n (%) 
29 Clinic inaccessible 0 (0%) 
30 Midwives competent 7 (25.0%) 
31 Shortage of doctors 16 (57.1%) 
32 Other 5 (17.9%) 
 Total 28 (100%) 
However, it was identified that the participants who indicated that they are competent has a lower 
knowledge mean (0.669), than those who indicated there is a shortage of doctors (0.683). 
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4.3.9 Variab les  33-37:  Ave rage  number o f c lients  
Table 4.9 shows the number of clients attending the clinic per day.  Most of the participants, n=43 
(42.6%), reported that ≤15 patients attend the antenatal clinic per day, followed by n=30 (29.7%), 
who indicated >20 ≤50 patients. Only n=7(6.9%), of the participants said there were more than 60 
clients attending the antenatal clinic per day.  
Table 4.9: Average number of clients attending the antenatal clinic per day (n = 101) 
Variables Average number of clients 
attending clinic 
n (%) 
33 ≤15 per day 43 (42.6%) 
34 >15≤20 12 (11.9%) 
35 >20≤50 30 (29.7%) 
36 >50≤60 9 (8.9%) 
37 >60 7 (6.9%) 
 Total 101(100%) 
4.3.10 Variab les  38-42:  Reg is te red  midwives  currently working  in  the  c linic   
Table 4.10 shows the number of registered midwives currently working in the clinic. A total of n=59 
(58.4%) participants indicated that there were 5 midwives working in their clinics while n= 20 
(19.8%) of them said there were three midwives  working in their clinics. 
Table 4.10: Registered midwives currently working in the clinic (n= 101) 
Variables Number of registered midwives 
working in the clinic 
n (%) 
38 1 1 (1%) 
39 2 9 (8.9%) 
40 3 20 (19.8%) 
41 4 12 (11.9%) 
42 5 59 (58.4%) 
 Total 101 (100%) 
4.4 SECTION B:  KNOWLEDGE OF HYPERTENSIVE DISORDERS IN PREGNANCY 
This section consists of questions 11 – 19. Each question has 2 – 3 options from which participants 
could choose the appropriate response. 
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4.4.1 Variab les  43-45:  Definition o f hypertens ion in  p regnanc y  
Table 4.11 shows that most of the participants, n=67 (66.3%), defined hypertension in pregnancy 
correctly as occurring when a systolic blood pressure is greater than or equal to 140 mmHg or 
diastolic blood pressure is less than or equal to 90 mmHg or mean arterial pressure is greater than 
or equal to 105 mmHg (43). The correct definition is supported by Peters and Flack (2003:209); 
Dafallah, El-Agib and Bushra (2003:369) and Roberts,eta el (2005:333).   
Table 4.11: Definition of hypertension in pregnancy 
Variables Knowledge about the definition of hypertensive 
disorders 
n (%) 
43 Systolic blood pressure ≥ 140mmhg or diastolic blood 
pressure ≤ 90mmHg or mean arterial pressure ≥ 105mmHg 
67 (66.3%) 
44 Systolic blood pressure ≥ 120mmHg or diastolic blood 
pressure ≥ 100mmHg or mean arterial pressure ≥ 
100mmHg 
13 (12.9%) 
45 Systolic blood pressure ≥ 130mmHg or diastolic blood 
pressure ≥ 100mmHg or arterial pressure ≥ 105mmHg 
21 (20.8%) 
 Total 101 (100%) 
However it is problematic that 34 (33.7%), have indicated the incorrect answer that may result in a 
misdiagnosis. A misdiagnosis may contribute to the increase in the morbidity and mortality rate 
(See paragraph 1.2). 
4.4.2 Variab les  46-48:  Definition o f ges tationa l hypertens ion   
Table 4.12 shows that n=57 (56.4%), of the participants defined gestation hypertension correctly 
as the onset of hypertension without proteinuria, after 20 weeks of pregnancy. Leeners, Neumaier-
Wager, Kuse, Irawan, Imthurn, and Rath, (2005:442); Lowdermilk and Perry (2007:787), support 
this definition. It is problematic that 44 (43.6%), of participants were unable to define gestational 
hypertension.   
Table 4.12: Definition of gestation hypertension 
Variables Definition of gestation hypertension n (%) 
46 Onset of hypertension without proteinuria, after 20 
weeks of pregnancy 
57 (56.4%) 
47 Onset of hypertension 2+ + of proteinuria within 20 
weeks pregnancy 
35 (34.7%) 
48 Onset of hypertension 2+ + of protein after 35 weeks of 
pregnancy 
9 (8.9%) 
 Total 101 (100%) 
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4.4.3 Variab les  49-51: Definition of chronic  hypertens ion  
Table 4.13 shows  that most of the participants n=71 (70.3%), defined chronic hypertension in 
pregnancy correctly as hypertension present before pregnancy or diagnosed before 20 weeks of 
gestation. 
Table 4.13: Definition of chronic hypertension 
Variables Definition of gestation hypertension n (%) 
49 Hypertension develops after 20 weeks of gestation and 
is characterized  by hypertension and proteinuria. 
18 (17.8%) 
50 Hypertension presents before the pregnancy or 
diagnosed before 20 weeks of gestation. 
71 (70.3% 
51 or diastolic blood pressure ≥ 110 mmHg and 
proteinuria > 29/24 hr urine specimen or ≥ 2+ on 
dipstick. 
12 (11.9% 
 Total 101 (100%) 
Leeners, Neumaier-Wager, Kuse, Irawan, Imthurn, and Rath (2005:442), Lowdermilk and Perry 
(2007:787), support this definition.  It is a concern that 30 (29.7%), of the participants do not know 
the definition. 
4.4.4 Variab les  52-54: Definition of p rote inuria   
Table 4.14 shows that most of the participants, n=61 (60.4%%), correctly defined proteinuria as 
urine concentration of greater than or equal to 30 mg/dl more in at least two random urine 
specimen collected at least 6 hours apart with no evidence of urinary tract infection.   
Table 4.14: Definition of proteinuria 
Variables Definition of chronic hypertension n (%) 
52 Urine concentration of ≤ 30mg/dl or more in at least 3 
hours apart with no evidence of infection. 
27 (26.7%) 
53 Urine concentration of ≤ 40mg/dl or more in at least 4 
hours apart with evidence of urinary tract infection. 
13 (12.9%) 
54 Urine concentration of ≥ 30mg/dl in at least two 
random urine    specimens collected at least 6 hours 
apart with no evidence of urinary tract infection. 
61 (60.4%) 
 Total 101 (100%) 
It is problematic that 40 (39.6%), of the participants were unable to define proteinuria. The correct 
answer is supported by Wolf, et al (2004:1330-1338). 
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4.4.5 Variab les  55- 57:  Definition o f ec lamps ia   
Table 4.15 shows that the majority of the participants, n=98 (97%), defined eclampsia correctly as 
the onset of seizure activity in the woman diagnosed with pre-eclampsia. This definition is 
supported by Peters and Flack (2003:209), Sellers (1997:1162), Zhang, Meikle and Trumble 
(2003:211). 
Table 4.15: Definition of eclampsia 
Variables Definition of eclampsia n (%) 
55 Hypertension present before pregnancy 1 (1.0%) 
56 Onset of seizure activity in the woman diagnosed with 
pre-eclampsia 
98 (97.0%) 
57 Onset of hypertension, without proteinuria after 20 
weeks of pregnancy 
2 (2.0%) 
 Total 101 (100%) 
4.4.6 Variab les  58-60:  Unders tand ing  p re -ec lamps ia   
Table 4.16 shows that the majority of participants n=73 (72.3%), indicated correctly that pre-
eclampsia is hypertension that develops after 20 weeks of gestation and is characterized by the 
presence of hypertension and proteinuria.  
It is problematic that 28 (27.7%), of participants incorrectly answered this question. The definition is 
supported by Emery (2005:346),  Coleman (2001:17), Molvarec et al. (2006:780) and Florio et al. 
(2006:1831), who defined pre-eclampsia as a hypertension that develops after 20 weeks of 
gestation and is characterized by the presence of hypertension and proteinuria. 
Table 4.16: Understanding pre-eclampsia 
Variables Understanding pre-eclampsia n (%) 
58 Hypertension develops after 20 weeks of gestation and 
is characterised by hypertension and proteinuria 
73 (72.3%) 
59 Hypertension  develops  after  28 wks  of  gestation  4 (4.0%) 
60 Hypertension  develops within  28 wks of  gestation  
and the  presence of proteinuria and  hypertension  
24 (23.7%) 
 Total 101 (100%) 
4.4.7 Variab les  61- 63: Majo r fac to rs  a s s oc iated  with deve lopment of p re -ec lamps ia    
Table 4.17 shows that n=57 (56.4%), of the participants indicated correctly that the major risk 
factor associated with the development of pre-eclampsia is obesity. It is problematic  that  44  
(43.6%),  is  unable  to  identify  the  risk  factors associated  with  the  development  of  pre-
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eclampsia. Andreasen, Andersen and Schantz (2004:1023), substantiate that the major factor 
associated with the development of pre-eclampsia is obesity. 
Table 4.17: Major risk factor associated with development of pre-eclampsia 
Variables Major risk  associated with  development  of  pre-
eclampsia  
n (%) 
61 Pneumonia 0 (0.0%) 
62 Cardiac  disease 44 (43.6%) 
63 Obesity  57 (56. 4%) 
 Total 101 (100%) 
4.4.8 Variab les  64-66: Mate rna l e ffects  of p re -ec lamps ia    
Table 4.18 shows that n=64 (63.4%), of the participants correctly indicated that the maternal 
effects of pre-eclampsia include intra-uterine growth retardation and convulsions. However, 
37(36.6%), of the participants were not able to identify the correct answer. 
The maternal effects of pre-eclampsia are supported by Emery (2005:346),  who  substantiates 
that the maternal effects of pre-eclampsia was caused by the intra uterine growth retardation and 
convulsions. 
Table 4.18: Maternal effects of pre-eclampsia 
Variables Maternal effects of pre-eclampsia n (%) 
64 Intra-uterine growth retardation and convulsions 64 (63.4%) 
65 Epigastric pain and visual problems 35 (34.6%) 
66 Aggressiveness and irritability 2 (2.0%) 
 Total 101 (100%) 
4.4.9 Variab les  67-69: Fe ta l e ffects  of ec lamps ia   
Table 4.19 shows that a total of n= 90 (89.1%), participants indicated correctly that the fetal effects 
of pre-eclampsia include reduced placental perfusion.  Gibson (2006:15) and Sellers (2005:1185), 
substantiate that the fetal effects of pre-eclampsia include reduced placental perfusion. 
Table 4.19: Fetal effects of pre-eclampsia 
Variables Fetal effects of pre-eclampsia n (%) 
67 Urinary output decrease 9 (8.9%) 
68 Epigastric pain 2 (2.0%) 
69 Reduced placental perfusion  90 (89.1%) 
 Total 101 (100%) 
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In conclusion to this section with reference to the knowledge about hypertensive disorders, the 
females had a higher knowledge mean score (0.551) than the males (0.504). In addition the 
knowledge means score of the basic one year diploma was the highest (0.555) followed by the 4 
year diploma (0.538) and the lowest 4-year degree (0.507). The knowledge means score of the 
participants where there are no doctors’ visits (0.587) are better than those who have doctors’ 
visits (0.529). Participants who indicated that they do not have any doctors because they are 
competent had a lower score (0.507) than those who indicated the reason for not having a doctor 
is because there is a shortage of doctors (0.604). A statistical significant association was identified 
between the period of experience and the knowledge about hypertensive disorders using the 
Spearman statistical test (p=<0.01). 
4.5 SECTION C:  ASSESSMENT AND DIAGNOSIS OF HYPERTENSIVE 
DISORDERS IN PREGNANT WOMEN 
This section consists of questions 20 – 37. Each question has 2 – 3 options from which the 
registered midwives are to choose the appropriate response. 
4.5.1 Variables 70-72: Subjective data pertaining to medical history   
Table 4.20 shows that the majority n=79 (78.2%), indicated correctly that renal diseases and 
diabetes mellitus are subjective data that must be collected pertaining to medical history. However, 
n=22 (21.8%), were not able to give the correct answer.  
Table 4.20: Subjective data pertaining to medical history 
Variables Subjective data pertaining to medical history  n (%) 
70 Fetal movements 20 (19.8%) 
71 Cultural believes 2 (2.0%) 
72 Renal diseases, diabetes mellitus 79 (78.2%) 
 Total 101 (100%) 
Thelma and James (1999:17) and Myers and Baker (2002:119), verify that renal disease and 
diabetes mellitus are subjective data that must be collected pertaining to medical history. 
4.5.2 Variab les  73-75: Soc ia l his to ry o f p regnant women  
Table 4.21 shows that the majority of participants, n=73 (72.3%), indicated correctly that the social 
history included drug abuse, alcohol and smoking. It is a concern that n=28 (27.7%), of the 
participants were not able to answer this question correctly. 
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Patient United Kingdom (2006: 6) and Fraser, Cooper and Nolte (2003:241), substantiate that 
when questioning patients about their social history the registered midwives should ask about drug 
abuse, alcohol and smoking. 
Table 4.21: Social history of a pregnant woman 
Variables Social history of a pregnant woman n (%) 
73 Smoking, renal disease and chronic hypertension 28 (27.7%) 
74 Diabetes, pregnancies after donor insemination 0 (0%) 
75 Drug abuse, alcohol and smoking 73 (72.3%) 
 Total 101 (100%) 
4.5.3 Variab les  76-78:  Clinica l manifes tations  o f p re -ec lamps ia   
Table 4.22 shows that n=96 (95%), of the participants indicated correctly that the presence of 
oedema and protein in urine are clinical manifestations of severe pre-eclampsia. This is supported 
by Sellers (2005:1164-1165) as well as Fraser, Cooper and Nolte (2003:381). 
Table 4.22: Clinical manifestation of pre-eclampsia 
Variables Clinical manifestation of pre-eclampsia n (%) 
76 Weight loss, abnormal blood pressure ≥ 160mmHg of 
systolic blood pressure 
3 (3%) 
77 Blood pressure changes from baseline, abnormal 
weight gain 
2 (2 %%) 
78 Presence of oedema and protein in urine 96 (95%) 
 Total 101 (100%) 
4.5.4 Variab les  79-81: Clinica l manifes tations  of s evere  p re -ec lamps ia   
Table 4.23 shows that n=57 (56.4%), of the participants correctly indicated that epigastric pain and 
headache as the clinical manifestations of severe pre-eclampsia. It is  problematic that n= 44 
(43.6%), of the participants failed to identify the correct answer. Emery (2005:348), verifies that 
epigastric pain and headache are the clinical manifestations of severe pre-eclampsia. 
Table 4.23: Clinical manifestation of severe pre-eclampsia 
Variables Clinical manifestation of severe pre-eclampsia n (%) 
79 Palpitations and tiredness 17 (16.8%) 
80 Headache, backache and sweating 27 (26.8%) 
81 Epigastric pain and headache 57 (56.4%) 
 Total 101 (100%) 
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4.5.5 Variab les  82-84:  As s es s ment o f oedema in p regnant women with 
hypertens ion  
Table 4.24 shows that n=92 (91.1%), of the participants indicated correctly the variable ‘to assess 
distribution, degree and pitting oedema when assessing oedema in pregnant women with 
hypertension’. Sellers (2005:1165), substantiates that when assessing oedema in pregnant women 
with hypertension distribution, degree and pitting are assessed. 
Table 4.24: How does one assess oedema in pregnant women with hypertension? 
Variables Assessing oedema in pregnant women with 
hypertension 
n (%) 
82 Assess distribution, degree and pitting 92 (91.1%) 
83 Assess the sacral region for oedema 3 (3.0%) 
84 Assess the existence of oedema on the abdomen 6 (5.9%) 
 Total 101 (100%) 
4.5.6 Variab les  85-87: Ins trument fo r meas uring  b lood  p res s ure   
Table 4.25 shows the majority of the participants  indicated correctly: n=81 (80%), selected manual 
sphygmomanometer and stethoscope as the instrument for measuring blood pressure to get the 
correct reading in pregnancy which is substantiated by Sellers (2005:1188). It is problematic that 
20 (19.8%), have incorrectly answered this question. 
Table 4.25: Instrument for measuring blood pressure 
Variables Instrument for measuring blood pressure n (%) 
85 Bimanual sphygmomanometer 1 (1.0%) 
86 Manual sphygmomanometer and stethoscope 81 (80.0%) 
87 Electronic blood pressure equipment 19 (18.8%) 
 Total 101 (100%) 
4.5.7 Variab les  88-91: Facto rs  affecting  b lood  p res s ure  read ing    
Table 4.26  shows that  n=69 (68.3%), indicated correctly that position and measuring techniques 
are the major factors affecting blood pressure readings, while it is a concern that n=32(31.7%), 
answered incorrectly. 
Huggins and De Swiet (2001:11) and Sellers (2005:1188), substantiate that position and 
measuring techniques are the major factors affecting blood pressure readings. 
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Table 4.26: Factors affecting blood pressure readings 
Variables Factors affecting blood pressure readings n (%) 
88 Alcohol consumption 9 (8.9%) 
89 Excitement 19 (18.8%) 
90 Position and measuring techniques 69 (68.3%) 
91 Exercises 4 (4.0%) 
 Total 101 (100%) 
 
4.5.8 Variab les  92-94: Appropria te  pos ition fo r co rrec t read ing  of b lood  p res s ure   
Table 4.27 shows that only n=39 (38.6%), of the participants answered correctly, while the majority 
n=62 (61.4%), answered incorrectly that the central position with arm at heart level is the most 
appropriate position for the correct reading of blood pressure. Peters and Flack (2003:210) and 
Huggins and De Swiet (2001:11), substantiate that the central position with arm at heart level is the 
most appropriate position for the correct reading of blood pressure. 
Table 4.27: Most appropriate position for the correct reading of blood pressure 
Variables Most appropriate position for the correct reading 
of blood pressure 
n (%) 
92 Left lateral position 62 (61.4%) 
93 Central with her arm at heart level 39 (38.6%) 
94 Standing up position 0 (0%) 
 Total 101 (100%) 
4.5.9 Variab les  95-96: Hypertens ion fo r the  teenager with b lood  p res s ure  o f 130/85 
mmHg  
Table 4.28 shows most of the participants n=77 (76.2%), indicated correctly that a blood pressure 
of 130/85 mmHg for a teenager may be indicative of hypertension as supported by Sellers 
(2005:1188). However, 24(23.8%), have incorrectly answered this question.  
Table 4.28: Hypertension for the teenager with a blood pressure of 130/85 mmHg 
Variables Hypertension for the teenager with a blood 
pressure of 130/85 mmHg 
n (%) 
95 Yes 77 (76.2%) 
96 No 24 (23.8%) 
 Total 101 (100%) 
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4.5.10 Variab les  97-98: The  bas e line  b lood  p res s ure  o f a  p regnant woman s hould  be  
de te rmined  in  the  firs t trimes te r o f p regnancy  
Table 4.29 shows that n=92 (91.1%), of the participants indicated correctly that it was preferable to 
determine the baseline blood pressure of a pregnant woman in the first trimester of pregnancy as 
substantiated by Nolte (1998:80). 
Table 4.29: Is it preferable to determine the baseline blood pressure of a pregnant woman in the first 
trimester of pregnancy? 
Variables 
 
When to determine baseline blood pressure of a 
pregnant woman in the first trimester of pregnancy 
n (%) 
97 Yes 92 (91.1%) 
98 No 9 (8.9%) 
 Total 101 (100%) 
4.5.11 Variab le  99-100:  Do  you a lways  us e  the  s ame  pos ition when meas uring  b lood  
p res s ure  o f a  p regnant woman?  
Table 4.30  shows that  n=87 (86.1%), of the participants indicated correctly that nurses should 
always use the same position when measuring the blood pressure of a pregnant woman as 
substantiated by Sellers (2005:1188). 
Table 4.30: Do you always use the same position when measuring the blood pressure of a pregnant 
woman? 
Variables 
 
Using the same position when measuring the 
blood pressure of a pregnant woman? 
n (%) 
99 Yes 87 (86.1%) 
100 No 14 (13.9%) 
 Total 101 (100%) 
4.5.12 Variab les  101-103:  Type  o f te s t fo r p re-ec lamps ia   
Table 4.31 shows that n=95 (94%), of the participants correctly answered that the preferred test for 
predicting pre-eclampsia was urine testing as substantiated by Cronje and Grobler (2006:505). 
Table 4.31: Type of test for pre-eclampsia 
Variables Tests for pre-eclampsia n (%) 
101 Bulbs test 2 (2%) 
102 None 4 (4%) 
103 Urine testing 95 (94.0%) 
 Total 101 (100%) 
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4.5.13 Variab les  104-106: Body a rea  fo r oedema dependency  
Table 4.32 shows that all the participants, n= 101(100%), correctly answered that the feet, ankles 
and sacral region are body areas for dependent oedema in a pregnant woman as supported by 
Sellers (2005: 1165). 
Table 4.32: Body area for oedema dependency 
Variables Body area for oedema dependency n (%) 
104 Hands, ankles and abdominal region 0 (0.0%) 
105 Eyes, ankles, sacral region 0 (0.0%) 
106 Feet, ankles and sacral region 101 (100.0%) 
 Total 101 (100%) 
4.5.14 Variab les  107-109: Unders tand ing  p itting  oedema 
Table 4.33 shows that the majority of the participants n=89 (88.1%), correctly answered that they 
understood pitting oedema as the oedema that leaves a small depression after a finger is applied. 
However, 12(11.9%), answered incorrectly.  
Table 4.33: Understanding pitting oedema 
Variables Understanding pitting oedema n (%) 
107 Oedema of lowest parts of the body 12 (11.9% 
108 Oedema that leaves a small depression after a finger 
is applied 
89 (88.1%) 
109 Oedema most likely to occur in the sacral region 0 (0.0%) 
 Total 101(100%) 
Sellers (2005:1165), describes pitting oedema as the oedema that leaves a small depression after 
a finger is applied.  
4.5.15 Variab les  110-112: Grades  us ed  to  as s es s  deep  tendon re flexes   
Table 4.34 shows that only n=54 (53.4%), of the participants answered correctly that grades used 
to assess deep tendon reflexes are  1+,2+,3+ & 4+ as substantiated by Du Plessis (2007:38). It is 
problematic that 47(46.6%), answered incorrectly. 
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Table 4.34: Grades used to asses deep tendon reflexes 
Variables Grades used to asses deep tendon reflexes n (%) 
110 1+, 2+, 3+ and 4+ 54 (53.4%) 
111 - 1, - 2, - 3 13 (12.9%) 
112 2%, 3% and 4% 34 (33.7%) 
 Total 101 (100%) 
4.5.16 Variab les  113-115: Tes t fo r a s s es s ing  fe ta l s ta tus   
Table 4.35 shows the majority of the participants n=76 (75.2%), correctly answered that the test for 
assessing fetal status is a lung test  for maturity and ultrasonography as   supported by Fraser, 
Cooper and Nolte (2003:342).  
Table 4.35: Test for assessing fetal status 
Variables Test for assessing fetal status n (%) 
113 Urinalysis 0 (0%) 
114 Lung test maturity and ultrasonography 76 (75.2%) 
115 Biophysical profile and fetal heart range  25 (24.8%) 
 Total 101 (100%) 
4.5.17 Variab les  116-118: Laborato ry te s ts  to  d iagnos e  p re -eclamps ia   
Table 4.36 shows that n=100 (99%), of the participants correctly answered that the laboratory tests 
to diagnose pre-eclampsia are blood and urine specimen as supported by Cronje and Grobler 
(2006:505). 
Table 4.36: Laboratory test to diagnose pre-eclampsia 
Variables Laboratory test(s) to diagnose pre-eclampsia n (%) 
116 Puss swab 0 (0.0%) 
117 Puss swab and bloods 1 (1.0%) 
118 Blood and Urine specimen 100 (99.0%) 
 Total 101 (100%) 
4.5.18 Variab les  119-121: Why is  a  b lood  s pec imen ob ta ined  fo r hypertens ive  
d is o rders ?   
Table 4.37 shows that  n=79 (78.2%), of the participants indicated correctly that a blood specimen 
is obtained to monitor the disease process, hepatic functioning and effects on renal system as 
supported by Sellers (2005:1175). 
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Table 4.37: Why is a blood specimen obtained for hypertensive disorders? 
Variables Blood specimen for hypertensive disorders  n (%) 
119 To monitor fetal growth 7 (6.9%) 
120 To identify infection 15 (14.9%) 
121 To monitor disease process, hepatic functioning and 
effects on renal system. 
79 (78.2%) 
 Total 101 (100%) 
In conclusion to this section with reference to the knowledge about the diagnosis and assessment 
of hypertensive disorders, it  can be noted that the males had a higher knowledge mean score 
(0.807) than the females (0.787). In addition the knowledge mean score of the basic one year 
diploma was the highest (0.794) followed by the 4 year degree (0.785) and the lowest 4-year 
diploma (0.784). The knowledge mean scores of the participants where there are no doctors’ visits 
(0.809) are better than those who have doctors’ visits (0.782). Participants who indicated that they 
do not have any doctors because they are competent had a lower score (0.785) than those who 
indicated the reason for not having a doctor is because there is a shortage of doctors (0.802). 
4.6 SECTION D.  MANAGEMENT OF HYPERTENSIVE DISORDERS IN 
PREGNANCY 
4.6.1 Variab les  122-124:  Prevention o f p re -ec lamps ia    
Table 4.38 shows that only n=29 (28.9%), of the participants correctly answered that they advised 
patients to use low dose aspirin, calcium, magnesium and zinc to prevent pre-eclampsia. It is 
problematic that 72 (71.3%), answered incorrectly. Myers and Baker (2002:122) and Peters and 
Flack (2003:213), substantiate that the pregnant woman who is suffering from hypertensive 
disorders should be advised to use low dose aspirin, calcium, magnesium and zinc. 
Table 4.38: Prevention of pre-eclampsia 
Variables Prevention of pre-eclampsia n (%) 
122 Use low dose aspirin, calcium, magnesium and zinc  29 (28.7%) 
123 Encourage low protein and sodium intake 24 (23.8%) 
124 Advice to pregnant woman to attend antenatal clinic at 
least every 3 months 
48 (47.5%) 
 Total 101 (100%) 
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4.6.2 Variab les  125-127: Advice  to  women with pre -ec lamps ia  regard ing  the ir d ie t  
Table 4.39 shows n=83 (82.2%), of the participants  correctly answered that the advice they give to 
patients with pre-eclampsia about their diet is the use of low salt and high protein  as supported by 
Nolte (1998:295) and Sellers (2005:1170).  
Table 4.39: Advice to women with pre-eclampsia regarding their diet 
Variables Advice to women with pre-eclampsia regarding 
their diet 
n (%) 
125 Use high sodium and high protein diet 1 (1.0%) 
126 Use low salt and high protein diet 83 (82.2%) 
127 Use vegetables and fish oil 17 (16.8%) 
 Total 101 (100%) 
4.6.3 Variab les  128-130: Type  o f s uitab le  re laxa tion fo r p regnant women with 
hypertens ion  
Table 4.40 shows only n=34 (33.6%),  of participants answered correctly that suitable relaxation for 
pregnant women is subdued  light and bed rest as supported by Duley (2003:167). It is problematic 
that 67(66.3%), incorrectly answered this question. 
Table 4.40: Type of suitable relaxation for pregnant women with hypertension 
Variables Suitable relaxation for pregnant women with 
hypertension 
n (%) 
128 Bed rest and stimulating environment 64 (63.4%) 
129 Quiet environment and subdued light 3 (3.0%) 
130 Subdued light and bed rest 34 (33.6%) 
 Total 101 (100%) 
4.6.4 Variab les  131-133: Why encourage  bed  res t?  
Table 4.41 shows n=85 (84.1%), of the participants answered correctly that bedrest improves 
utero-placental blood flow as supported by Nolte (1998:295). 
Table 4.41: Why encourage bed rest? 
Variables Why encourage bed rest? n (%) 
131 To improve utero-placental blood flow 85 (84.1%) 
132 To improve blood flow to the uterus 2 (2.0%) 
133 To encourage growth of the fetus 14 (13.9%) 
 Total 101(100%) 
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4.6.5 Variab les  134-136: Cons ulta tion by midwife   
Table 4.42 shows that n=60 (59.4%), of the participants answered correctly that  pregnant women 
should consult the midwife on a weekly basis as supported by Cronje and Grobler (2006:491).  
Table 4.42: Consultation by midwife 
Variables Consultation by midwife n (%) 
134 Once a month 16 (15.8%) 
135 Twice a month 25 (24.7%) 
136 Weekly 60 (59.4%) 
 Total 101 (100%) 
4.6.6 Variab les  137-139: Treatment o f p re -ec lamps ia    
Table 4.43 shows that the majority of participants, n=96 (95%), correctly answered that 
magnesium sulphate, aldomet and hydrolazine may be prescribed for pre-eclampsia as supported 
by Fraser, Cooper and Nolte (2003:343). 
Table 4.43: Treatment for pre-eclampsia 
Variables Treatment for pre-eclampsia n (%) 
137 Phenobarbitone  3 (3%) 
138 Diuretics e.g. Lasix 2 (2.0%) 
139 Magnesium sulphate, aldomet and hydralazine 96 (95.0%) 
 Total 101 (100%) 
4.6.7 Variab les  140-142: Route  to  be  us ed  fo r the  adminis tra tion of magnes ium 
s ulpha te   
Table 4.44 shows that only n=27 (26.7%), of the participants correctly answered that magnesium 
sulphate may be administered intravenously or intramuscular as supported by Emery (2005:348) 
and Cronje and Grobler (2006:512). However, it is problematic that 74 (73.3%), answered 
incorrectly. 
Table 4.44: Administration route for magnesium sulphate  
Variables Administration route for magnesium sulphate  n (%) 
140 Intramuscularly only 9 (8.9%) 
141 Intravenously or intramuscular 27 (26.7%) 
142 Intravenously only 65 (64.4%) 
 Total 101 (100%) 
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4.6.8 Variab les  143-145: Time  o f re fe rra l fo r p regnant women with hypertens ive  
d is o rders   
Table 4.45 shows that  only n=53 (52.5%), of the participants correctly answered that a pregnant 
woman should be referred when she is not responding to the management given by the midwife as 
supported by Cronje and Grobler (2006:494) and Sellers (2005:1170). However, it is problematic 
that 48 (47.5%), answered incorrectly.  
Table 4.45: Time of referral for pregnant women with hypertensive disorder 
Variables Time of referral for pregnant women with 
hypertensive disorder 
n (%) 
143 When the woman is not responding to the 
management given by the midwife 
53 (52.5%) 
144 When the woman is presenting a rapid rise in blood 
pressure, rapid gain in weight and severe headache 
45 (44.5%) 
145 When the woman presents with oliguria 3 (3%) 
 Total 101 (100%) 
In conclusion to this section with reference to the knowledge about the management of 
hypertensive disorders, it is noted that the males had a higher knowledge mean score (0.605) than 
the females (0.512). In addition the knowledge mean score of the 4 year degree was the highest 
(0.544) followed by the 4 year diploma (0.534) and the lowest the basic one year diploma (0.514). 
The knowledge mean scores of the participants where there are no doctors’ visits (0.544) are 
better than those who have doctors’ visits (0.517). Participants who indicated that they do not have 
any doctors because they are competent had a higher score (0.589) than those who indicated the 
reason for not having a doctor is because there is a shortage of doctors (0.507). A significant 
statistical association has been identified between period of experience and the management of 
hypertensive disorders using the Spearman statistical test (p=0.02). 
4.7 CONCLUSION 
The purpose of this chapter was to present the findings of the study investigated scientifically about 
the knowledge of the registered midwives managing hypertensive disorders in pregnancy working 
at Primary Health Care level in the Buffalo City Local Service Area of the Eastern Cape. This goal 
as set was reached together with the specific objectives namely to determine whether the 
registered midwives working in Primary Health Care have adequate knowledge about: 
• hypertensive disorders in pregnancy (Section B) 
• the diagnosis and assessment of hypertensive disorders in pregnancy (Section C)  
• the management of hypertensive disorders in pregnancy (Section D). 
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In chapter 5 discussion about the data analysis, conclusions and recommendations of the specific 
objectives will be discussed.  
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CHAP TER 5: DISCUSSIONS, CONCLUSIONS AND 
RECOMMENDATIONS 
5.1 INTRODUCTION  
In this chapter the researcher presents a discussion on the data analysis, conclusions with 
reference to the findings and various recommendations based on the scientific evidence obtained 
from this study.  
Peters and Flack (2003:209), as described in paragraph 1.2, identified in their research studies that 
hypertensive disorders are a serious problem complicating 6% to 8% of all pregnancies. They 
conclude that nurses working in outpatient home care and acute care settings must be vigilant 
when assessing pregnant women so that hypertensive problems are identified early and treated 
promptly. Furthermore, nurses must have knowledge about the procedures required to ensure 
accuracy and to make informed decisions based on this knowledge. Adequate management of 
these women will promote the safe and healthy delivery. Furthermore, hypertensive disorders are 
the major contributor to maternal and infant morbidity and mortality rates as described in paragraph 
1.2. 
5.2 DISCUSSION 
5.2.1 Biographica l da ta 
The findings show that the majority of the participants working in the clinics where the research 
was conducted are older than 40 years of age (66.3%). The staff component of registered 
midwives shows an aging /midwifery population in the Buffalo City Local Service Area. The 
majority of the participants were female (87.1%), this distribution shows the dominance of females 
in the profession which is substantiated by Kelly (2006:27). The clinics showed a qualification mix 
between the participants, namely a one year basic diploma in midwifery (52.4%), 4-year 
comprehensive nursing diploma (32.6%) and 4 year nursing degree (13.9%) however, only one 
(1.0%) participant was qualified as an advanced midwife.  
The participants with a One Year Basic Midwifery Diploma in Nursing obtained the highest 
knowledge score as shown in figure 4.1, followed by the 4-year diploma and then the 4year 
degree. All the participants regardless of the specific programme they have followed completed 
their midwifery according to Regulation 254 Basic Midwifery as promulgated by the Nursing Act 50 
of 1978. It would therefore have been expected that participants who hold a degree qualification 
would have obtained better scores. However, a possible reason why the one-year basic diploma 
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obtained the highest scores could be attributed to the continuous practice in midwifery while the 4 
year diploma/degree students have an interrupted midwifery programme.  
A statistical correlation was shown between the presence of doctors and the knowledge of the 
midwives using the Mann-Whitney statistical test (p=0.04). In clinics where there are no doctors’ 
visits the knowledge of the staff was higher (0.691) than the total knowledge mean score (0.666). 
Where doctors are regularly visiting the clinics the mean knowledge score is lower (0.656), than 
the total knowledge mean. However, it was identified that the participants who indicated that they 
are competent have a lower knowledge mean (0.669), than those who indicated that there is a 
shortage of doctors (0.683). These results show that where midwives do not have any additional 
support as when there are doctors’ present, individual effort is made to keep up to date as they are 
practising as independent practitioners.  
5.2.2 Sec tion B:  Ob jec tives  o f the  s tudy  
5.2.2.1 To determine whether the registered midwives working in Primary Health Care 
have adequate knowledge about hypertensive disorders in pregnancy (Section 
B) 
The knowledge and understanding of the midwife about hypertensive disorders in pregnancy 
cannot be emphasised enough. This is currently still one of the major contributors towards 
maternal and infant morbidity and mortality (See paragraph 1.2).  The results obtained in this 
section show that inadequate knowledge does exist among the midwives who participated in this 
study. The findings obtained related to this objective show that 25-40% of the questions were 
incorrectly answered. Despite the fact that no statistical significance was shown between 
knowledge and hypertensive disorders it is a concern that such poor results were obtained on a 
disorder of such critical importance in the clinical environment. This is substantiated by the findings 
of the following questions about hypertensive disorders:  It was identified that midwives (33.7%) 
were not able to define a hypertensive disorder,  in addition 27.7% of participants  had no 
understanding about pre-eclampsia.   A  major risk factor associated with the development of pre-
eclampsia is obesity, however, 43.6% incorrectly answered this question. Furthermore, the effect 
of pre-eclampsia on the mother and fetus were poorly answered namely, 36.6% and 10.9% 
respectively do not know these effects. The results are further verified by the fact that the 
knowledge means score of the participants (0.587) where there are no doctors’ visits are better 
than those who have doctors’ visits (0.529). These results show that where the midwives practise 
independently without the support of a doctor they tend to ensure that they deliver a safe practice 
by keeping their knowledge up to date. However in clinics where they have the support of doctors, 
the knowledge is poorer. A Man-Whitney statistical test shows a significant statistical association 
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between the knowledge of staff in clinics where doctors are visiting regularly and where there are 
no visits (p=0.04). 
It can therefore be concluded that the knowledge of the midwives about hypertensive disorders in 
pregnancy are inadequate.  
5.2.2.2 To determine whether the registered midwives working in primary health care 
setting have adequate knowledge about the assessment and diagnosis  of 
hypertensive disorders in pregnancy (Section C).  
The assessment of a pregnant woman is of critical importance as a misdiagnosis may result in 
severe complications and even death. The results obtained in this section varied but shows that 
inadequate knowledge does exist among the midwives who participated in this study.  
Table 4.20  shows that 21.8%, was not able to give the correct answer that renal diseases and 
diabetes mellitus are subjective data that must be collected pertaining to medical history. 
Furthermore  27.7%, as shown in table 4.21, was not able to give the correct answer  that the 
research into social history  should include drug abuse, alcohol and smoking.  These are important 
aspects of history taken during the assessment phase to prevent complications (See paragraph 
2.8.). 
Results also show that the knowledge of participants is inadequate with regard to the clinical 
manifestations of pre-eclampsia with which a patient presents. Table 4.22 shows that 43.6% of the 
participants failed to correctly indicate that epigastric pain and headache are clinical manifestations 
of severe pre-eclampsia. In addition there are participants who failed to answer correctly that 
manual sphygmomanometer and stethoscope are the instruments for measuring blood pressure to 
get the correct reading in pregnancy.  Results obtained also show that 31.7% of the participants 
failed to indicate that the position and measuring techniques are major factors affecting blood 
pressure readings.  In measuring blood pressure, table 4.28 shows that 23.8% failed to identify that 
a blood pressure of 130/85 mmHg for a teenager may be indicative of hypertension.  The 
appropriate technique for blood pressure taking is of extreme importance as this is the core to the 
diagnosis of hypertension.  
In this section the knowledge mean scores of the participants where there are no doctors’ visits 
(0.809), are better than those who have doctors’ visits (0.782). Participants who indicated that they 
do not have any doctors because they are competent had a lower score (0.785), than those who 
indicated the reason for not having a doctor is because there is a shortage of doctors (0.802). 
Again the results show that where doctors are regularly visiting the clinics the midwives tend to be 
less responsible in terms of updating their knowledge in midwifery and a false idea of them being 
competent is problematic. 
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The researcher therefore concludes that the knowledge of midwives about the assessment and 
diagnosis of patients with a hypertensive disorder is inadequate. 
5.2.2.3 To determine whether the registered midwives working in Primary Health Care 
have adequate knowledge about the management of hypertensive disorders in 
pregnancy (Section D). 
It is problematic that 72 (71.3%), are not able to advise the pregnant woman who is suffering from 
hypertensive disorders to use low dose aspirin, calcium, magnesium and zinc as substantiated by 
Myers and Baker (2002:122) and Peters and Flack (2003:213). In addition 17.8% of the 
participants failed to show that they advise patients with pre-eclampsia to use a low salt and high 
protein diet  as supported by Nolte (1998:295) and Sellers (2005:1170). Only 33.6%  of participants 
answered correctly that suitable relaxation for pregnant women is subdued  and bed rest is light as 
supported by Duley (2003:167) as shown in table 4.40. 
Only (26.7%) of the participants correctly answered that magnesium sulphate may be administered 
intravenously or intramuscular as supported by Emery (2005:348) and Cronje and Grobler 
(2006:512). However, it is problematic that (73.3%) answered incorrectly.  Results further show 
that 41% of the midwives do not have the knowledge of how often a patient with a hypertensive 
disorder should consult a midwife.  
The knowledge mean scores of the participants pertaining to this section show that where there 
are no doctors’ visits knowledge scores are better (0.544), than those who have doctors’ visits 
(0.517).  This result shows the responsibility towards patient safety of the independent individual 
practitioner who has no support of a medical doctor in the clinical environment, in maintaining her 
knowledge level about the management of the patients with a hypertensive disorder. A significant 
statistical association has been identified between period of experience and the management of 
hypertensive disorders using the Spearman statistical test (p=0.02).  
The researcher concludes that the knowledge of registered midwives working in primary health 
care who are managing hypertensive disorders in pregnancy is inadequate.  
5.3 RECOMMENDATIONS  
Recommendations are based on the scientific evidence obtained in this study and is especially 
made to the relevant stakeholders in policymaking and training of midwives. 
These recommendations will focus on the improvement of the knowledge of registered midwives 
with regard to the assessment, diagnosis and management of hypertensive disorders in 
pregnancy. The implementation of these recommendations may have a positive influence in 
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decreasing the maternal and neonatal morbidity and mortality rates. Emphasis is placed on the 
early detection and management of hypertensive disorders at primary health care level.  
5.3.1  Res pons ibility o f Policy makers  and  Hea lth Service  p roviders  
It is the responsibility of the policy makers and health service providers to ensure that the 
registered midwives are provided with the necessary opportunity to improve their knowledge and 
skills in how to assess, diagnose and effectively manage hypertensive disorders in pregnancy.  
5.3.1.1 Attendance of workshops, congresses, conferences and symposiums 
The attendance of regular annual workshops, congresses, conferences and symposiums should 
be made essential for all midwives.Midwives should be given these learning opportunities on a 
rotating basis and reports should be compulsory and be made available to all.  
5.3.1.2 Regular update and in-service training 
Midwives should be given a regular update on a monthly basis on new developments in midwifery. 
With the introduction soon of the regulation regarding continuous professional development as will 
be promulgated by the Nursing Act 33 of 2005, opportunities should be created for the midwives to 
continuously improve their knowledge. In-service training should be given on a weekly basis.  
5.3.1.3 Competency in practical skills 
Basic procedures such as taking a blood pressure should not be seen as a ritual but a core 
function in diagnosing a hypertensive disorder. Regular demonstrations and testing for 
competence in taking blood pressures should be done by external evaluators or with the support of 
a university. The interpretation of readings and related problems should also be evaluated. 
5.3.1.4 Formal education training 
A concerted effort should be made by the national or provisional departments of health  to ensure 
that all obstetric units in primary health care facilities be managed by trained advanced midwives. 
Study opportunities together with bursaries should be made available annually to midwives to 
complete a post-graduate qualification in advanced midwifery.   
5.3.2 Qua lity as s urance  p rogrammes  
The introduction of a quality assurance programme will provide each clinic with specific indicators 
against which the quality of the service will be measured. A specific roster designed for regular 
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quality assurance audits of the clinics should be undertaken. This should be done on a monthly 
basis by the unit manager and at least three monthly by the district managers. 
5.3.2.1 Incentives for improving knowledge and skills 
Incentives should be introduced for those midwives who on an individual basis show excellence in 
patient care. Specific criteria should be set against which midwives will be measured. By 
introducing these incentives it will contribute positively towards patient care.   
5.3.2.2 Incentives for primary health care facilities 
Indicators to monitor the quality of care in a primary health care facility should be identified and 
monitored such as high maternal and fetal morbidity rates, complications and misdiagnosis. The 
introduction of patient satisfaction surveys on a regular basis contribute to the quality of care being 
given. It is recommended that these surveys be done monthly.  
Clinics should be rewarded for outstanding achievements regarding patient care. By bringing 
awareness about the quality of patient care being given, which includes detailed assessment, 
accurate diagnosis and efficient and effective management, it is probable also that this will lead to 
a decrease in morbidity and mortality rates.  
5.3.2.3 Guidelines, policies and procedures 
The development of the required guidelines, policies and procedures should be in place to guide 
the staff in how to manage patients with reference to all aspects of patient care. These guidelines, 
policies and procedures should be generic to all primary health care clinics and be available and 
easily accessible to all midwives. Policies should include an appropriate referral system available 
in every community health service (clinic) to ensure early referral of women with signs of 
hypertensive disorders in pregnancy.  
5.3.3 Patient educa tion   
5.3.3.1 Education programme 
A patient education programme emphasising conditions and complications during pregnancy 
should be available in all the clinics. Booklets, pamphlets and brochures guiding the pregnant 
woman should be made available to every new obstetric patient. This guide should inform the 
patient of expectations, problems, do’s and don’ts during pregnancy, substance and alcohol abuse, 
smoking and any clinical manifestation of any condition.  The use of posters in the clinics and  
viewing DVDs  
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while waiting adds to the knowledge base of the patient.  The early detection of clinical 
manifestations is critical to ensure adequate management.  
5.3.3.2 Community interaction 
The role of the midwife is critical in ensuring that healthy bouncing babies are born. Therefore the 
midwife’s role in the community cannot be underestimated as she plays a pivotal role in teaching 
women about a healthy pregnancy. Seminars, workshops and health days emphasising a healthy 
pregnancy should regularly be undertaken. The midwife should take ownership of the health of the 
women of the community the clinic serves. 
5.3.4 Evidence  bas ed  res ea rch 
This study has provided a bench mark about the knowledge of midwives in primary health care 
facilities. It is possibly the “tip of the iceberg” about what midwives know about the conditions they 
manage in the clinical environment.  A compounding effect may exist with reference to all 
conditions, that existing knowledge of midwives are questioned. Further research is therefore 
recommended for all conditions being managed by the midwife.  
5.4 CONCLUSION 
The research question which guided this study “Do the registered midwives working at Primary 
Health Care level have adequate knowledge about the management of hypertensive disorders in 
pregnancy?” has been answered.  This research question was scientifically investigated and it is 
concluded based on the evidence that the midwives working in primary health care do not have 
adequate knowledge about hypertensive disorders in pregnancy. 
By empowering the midwife it will result in early detection and management of hypertensive 
disorders at primary health care level. The midwives should therefore be knowledgeable and 
competent in the assessment and identification of pregnant women who are at risk of developing 
hypertensive disorders and management of those who have been identified (Motherhood 
Programme, 1999-2001:71). 
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Annexure A: 
QUESTIONNAIRE  
Title: An evaluation of the knowledge of registered midwives managing hypertensive disorders in pregnancy at 
Primary Health Care level in the Eastern Cape. 
  
Goal of the Study 
 
The goal of this study is to evaluate the knowledge of midwives managing hypertensive disorders in pregnancy at 
Primary Health Care level. 
All information will be treated as confidential and the researcher undertakes not to reveal any individual information that 
appears in this questionnaire. 
To complete this 8 page questionnaire will take approximately 30 minutes. All you need to do is to mark off with a cross 
(x) your most appropriate response(s) as illustrated in the example below. 
 
EXAMPLE 
8 4 year degree in General Nursing and Midwifery (Psychiatry & Community 
Health science) 
 
9 4 years diploma in General Nursing and Midwifery (Psychiatry & Community 
Health science) 
X 
10 1 year basic diploma in Midwifery   
11 Advanced diploma in Midwifery   
12 Other(s)  Specify  
 
SECTION A:  BIOGRAPHICAL DATA 
 
1. What is your age? 
1 ≥ 21  ≤ 30 years  
2 > 30 years  ≤ 40 years  
3 > 40 years ≤ 50 years  
4 > 50 years  ≤ 60 years  
5 > 60 years  
 
2.  What is your Gender? 
6 Male  
7 Female  
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3.  Indicate your qualification(s) in midwifery? 
8 4 year degree in General Nursing and Midwifery (Psychiatry & Community 
Health Science) 
 
9 4 years diploma in General Nursing and Midwifery (Psychiatry & Community 
Health Science) 
 
10 1 year basic diploma in Midwifery   
11 Advanced diploma in Midwifery   
12 Other(s) Specify   
 
4. Indicate the  duration of your experience as a midwife? 
13 ≤ 6 months  
14 > 6 months  ≤ 3 years  
15 > 3 years  ≤ 5 years  
16 > 5 years  ≤ 7 years  
17 > 7 years  
 
5. Indicate the length of your (current) experience as a midwife at this clinic? 
18 ≤ 6 months    
19 > 6months ≤ 1 year  
20 >1 year ≤ 3 years  
21 > 3 years  ≤ 5 years  
22 > 5 years  
 
6. Do doctors regularly visit the clinic? 
23 Yes  
24 No  
 
7. If you answered “yes” to question 6, how often does a doctor visit the clinic? 
25 Daily  
26 Once a week  
27 Once a month  
28 Other(s)  Specify  
 
8. If you answered “No” to question 6 indicate  why do you think this is not happening? 
29 Clinic is inaccessible  
30 Midwives are competent  
31 Shortage of doctors  
32 Other(s)  Specify  
 
9. How many clients on average attend the antenatal clinic per day? 
33 <15  
34 ≥ 15 < 20  
35 ≥ 20 < 50  
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36 ≥ 50 < 60  
37 ≥ 60   
 
10. How many registered midwives are working currently in the clinic? 
 
38 1  
39 2  
40 3  
41 4  
42 5  
 
SECTION B:  KNOWLEDGE OF HYPERTENSIVE DISORDERS IN PREGNANCY 
Choose the most appropriate response(s). 
 
11. Indicate how you would define hypertension in pregnancy? 
43 Systolic blood pressure ≥ 140mmhg or diastolic blood pressure ≤ 90mmHg 
or mean arterial pressure ≥ 105mmHg 
 
44 Systolic blood pressure ≥ 120mmHg or diastolic blood pressure ≥ 100mmHg 
or mean arterial pressure ≥ 100mmHg 
 
45 Systolic blood pressure ≥ 130mmHg or diastolic blood pressure ≥ 100mmHg 
or arterial pressure ≥ 105mmHg. 
 
 
12. Indicate the most appropriate definition of gestation hypertension  
46 Onset of hypertension without proteinuria, after 20 weeks of pregnancy?  
47 Onset of hypertension 2+ + of proteinuria within 20 weeks pregnancy?  
48 Onset of hypertension 2+ + of protein after 35 weeks of pregnancy?  
 
13. Indicate the most appropriate definition of chronic hypertension in pregnancy  
49 Hypertension develops after 20 weeks of gestation and characterised by 
hypertension and proteinuria. 
 
50 Hypertension present before the pregnancy or diagnosed before 20 weeks of 
gestation. 
 
51 Presence of systolic blood pressure ≥ 160mmHg or diastolic blood pressure 
≥ 110 mmHg and proteinuria > 29/24 hr urine specimen or ≥ 2+ on dipstick 
 
 
14.  Define proteinuria 
52 Urine concentration of ≤ 30mg/dl or more in at least 3 hours apart with no 
evidence of infection. 
 
53 Urine concentration of ≤ 40mg/dl or more in at least 4hours apart with 
evidence of urinary tract infection 
 
54 Urine concentration of ≥ 30mg/dl in at least two random urine    specimens 
collected at least 6 hours apart with no evidence of urinary tract infection. 
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15.  What is eclampsia? 
55 Hypertension present before pregnancy  
56 Onset of seizure activity in the woman diagnosed with pre-eclampsia  
57 Onset of hypertension, without proteinuria after 20 weeks of pregnancy  
 
16.   What is your understanding of  pre-eclampsia? 
58 Hypertension develops after 20 weeks of gestation and is characterised by 
hypertension and proteinuria 
 
59 Hypertension develops after 28 weeks of gestation  
60 Hypertension develops within 28 weeks of gestation and is characterised by 
proteinuria and hypertension 
 
 
17. Indicate the major risk factor associated with the development of pre-eclampsia 
61 Pneumonia  
62 Cardiac diseases  
63 Obesity  
 
18. Indicate the maternal effects of pre-eclampsia 
64 Intra-uterine growth retardation and convulsions  
65 Epigastric pain and visual problems  
66 Aggressiveness and irritability  
 
19. Indicate the fetal effect of pre-eclampsia 
67 Urinary output decrease  
68 Epigastric pain  
69 Reduced placental perfusion   
 
SECTION C:  ASSESSMENT AND DIAGNOSIS OF HYPERTENSIVE DISORDERS IN A PREGNANT WOMAN  
Choose the most appropriate response(s) 
 
20. Indicate which subjective data  you will collect pertaining to the medical history 
70 Fetal movements  
71 Cultural believes  
72 Renal diseases, diabetes mellitus  
 
21. Indicate which aspects about her social history you will ask the pregnant woman  
73 Smoking, renal disease and chronic hypertension  
74 Diabetes, pregnancies after donor insemination  
75 Drug abuse, alcohol and smoking  
 
22. Indicate the clinical manifestations of pre-eclampsia 
76 Weight loss, abnormal blood pressure ≥ 160mmHg of systolic blood pressure  
77 Blood pressure changes from baseline, abnormal weight gain  
78 Presence of edema and protein in urine.  
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23. Indicate the clinical manifestations of severe pre-eclampsia 
79 Palpitations and tiredness  
80 Headache, backache and sweating  
81 Epigastric pain and headache  
 
24. How do you assess edema in a pregnant women with hypertension? 
82 Assess distribution, degree and pitting  
83 Assess the sacral region for edema  
84 Assess the existence of edema on the abdomen  
 
25.  What instrument(s) do you use to measure the blood pressure to get the correct reading in pregnancy? 
85 Bimanual sphygmomanometer  
86 Manual sphygmomanometer and stethoscope  
87 Electronic blood pressure equipment  
 
26. Which of the following factor(s) affect blood pressure readings? 
88 Alcohol consumption  
89 Excitement  
90 Position and measuring techniques  
91 Exercises  
 
27. What is the most appropriate position for the correct reading of blood pressure? 
92 Left lateral position  
93 Central with her arm at heart level  
94 Standing up position  
 
28.  For the teenager a blood pressure of 130/85 mmHg may be indicative of hypertension 
95 Yes  
96 No  
 
29.  It is important to determine the baseline blood pressure of a pregnant woman in the first trimester of 
pregnancy 
97 Yes  
98 No  
 
30.   You must always use the same position when measuring the blood pressure of a pregnant woman 
99 Yes  
100 No  
 
31. Which test could be used as a routine screening tool for predicting pre-eclampsia? 
101 Bulbs test  
102 None  
103 Urine testing  
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32. In which areas of the body do you find dependent edema in a pregnant woman? 
104 Hands, ankles and abdominal region  
105 Eyes, ankles, sacral region  
106 Feet, ankles and sacral region  
 
33. What is pitting edema? 
107 Edema of lowest parts of the body  
108 Edema that leaves a small depression after a 
finger is applied to it 
 
109 Edema most likely to occur in the sacral region  
 
34. Which grades can be used to assess deep tendon reflexes? 
110 1+, 2+, 3+ and 4+  
111 - 1, - 2, - 3  
112 2%, 3% and 4%  
 
35. Which test can be done to assess fetal status? 
113 Urinalysis  
114 Lung test maturity and ultrasonography  
115 Biophysical profile and fetal heart range   
 
36. Which laboratory test(s) would you do for diagnosis of pre- eclampsia?  
116 Puss swab  
117 Puss swab and bloods  
118 Blood and Urine specimen  
 
37. Why is a blood specimen obtained for hypertensive disorders? 
119 To monitor fetal growth  
120 To identify infection  
121 To monitor disease process, hepatic functioning 
and effects on renal system. 
 
 
SECTION D: MANAGEMENT OF HYPERTENSIVE DISORDERS IN PREGNANCY 
Choose the most appropriate response(s) 
 
38. How will you prevent pre-eclampsia? 
122 Use low dose aspirin, calcium, magnesium and zinc intake  
123 Encourage low protein intake and encourage sodium intake  
124 Advice to pregnant woman to attend antenatal clinic at least every 
3 months 
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39. What dietary advice  can you give to a woman with pre-eclampsia?  
125 Use high sodium and high protein diet  
126 Use low salt and high protein diet  
127 Use vegetables and fish oil  
 
40. To encourage relaxation in pregnant women with hypertension what would you recommend? 
128 Bed rest and stimulating environment  
129 Quiet environment and subdued light  
130 Subdued light and bed rest  
 
41.  Why would you encourage bed rest? 
131 To improve utero-placental blood flow  
132 To improve blood flow to the uterus  
133 To encourage growth of the fetus  
 
42.  How often should the midwife see a pregnant woman who is presenting with a hypertensive disorder? 
134 Once a month  
135 Twice a month  
136 Weekly  
 
43. What treatment would you prescribe for pre-eclampsia? 
137 Phenobarbitone   
138 Diuretics e.g. Lasix  
139 Magnesium sulfate, aldomet and hydralazine  
 
44.  By which route should magnesium sulfate be administered? 
140 Intramuscularly only  
141 Intravenously or intramuscular  
142 Intravenously only  
 
45.  When should the midwife refer a pregnant woman presenting with a hypertensive disorder? 
143 When the woman is not responding to the management given by 
the midwife 
 
144 When the woman is presenting with rapid rise in blood pressure, 
rapid gain in weight and severe headache 
 
145 When the woman presents with oliguria  
 
Thank you. 
Nompumelelo Nkwekazi 
M Cur Student 
Cell No: 0739719863 
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Annexure C: Approval from the Department of Health 
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Annexure D: Participant information leaflet and consent form 
TITLE OF THE RESEARCH PROJECT:  
 
AN evaluation of the knowledge of the registered midwives managing hypertensive 
disorders at the Primary Health Care level in the Eastern Cape.  
 
REFERENCE NUMBER: 14486148 
 
PRINCIPAL INVESTIGATOR: L.N. Ngwekazi 
 
ADDRESS:  
P. O. Box 4381 
King William’s Town 
5600 
 
 
CONTACT NUMBER:  
 
Home: 043 642 6625 
Cell: 073 971 9863 
Work: 043 709 2411 
 
 
You are being invited to take part in a research project.  Please take some time to read the 
information presented here, which will explain the details of this project.  Please ask the 
study staff any questions about any part of this project that you do not fully understand.  It 
is very important that you are fully satisfied that you clearly understand what this research 
entails and how you could be involved.  Also, your participation is entirely voluntary and 
you are free to decline to participate.  If you say no, this will not affect you negatively in 
any way whatsoever.  You are also free to withdraw from the study at any point, even if 
you do agree to take part. 
 
This study has been approved by the Committee for Human Research at Stellenbosch 
University and will be conducted according to the ethical guidelines and principles of 
the international Declaration of Helsinki, South African Guidelines for Good Clinical 
Practice and the Medical Research Council (MRC) Ethical Guidelines for Research. 
 
What is this research study all about? 
This study will be conducted at Buffalo Local Service area. The purpose of this study is to 
investigate scientifically the knowledge of the midwives working at Primary Health Care 
level regarding hypertensive disorders in pregnancy.  
OBJEECTIVES 
 
 To determine whether the knowledge of midwives working in Primary Health Care 
regarding the assessment in pregnancy for hypertensive disorders is adequate.  
 To determine whether the midwives working in Primary Health Care are able to 
diagnose a hypertensive disorder in pregnancy.  
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 To determine whether the knowledge of midwives working in Primary Health Care 
in the management of hypertensive disorders in pregnancy are adequate 
 
Population for this study will consist of registered midwives working in the Buffalo City 
Local Service Area, both in the rural and urban clinics. 
Data will be collected by means of a structured questionnaire consisting of mostly closed 
ended questions. Questionnaires will be distributed to individual midwives personally for 
completion and will be collected separately from the consent form by the researcher on the 
same day. All data will be managed anonymously, be accessible only to the researcher 
and will be discarded after the completion of the study. 
 
Why have you been invited to participate? 
You have been invited to participate in this study being one of the students who are 
regularly placed into the Primary Health Care Level.  
 
What will your responsibilities be? 
You will participate in this study by filling in the questionnaire within ten (10) minutes and 
handing it over to the student researcher on the same day.  
 
You will be asked to sign the attached consent form as proof of agreement to participate 
before you can fill the questionnaire. This is an important document to show that you freely 
agreed to participate. 
 
Will you benefit from taking part in this research? 
You have no specific benefit by participating in the study, on. The results of the study 
might possibly contribute to the development of the registered midwives in the province 
and the country in general. 
 
Are there in risks involved in your taking part in this research? 
There is no foreseen risk that is related to your participation in this project. The information 
you will provide will be totally anonymous. Consent form and questionnaire will be placed 
in separate envelopes. 
 
If you do not agree to take part, what alternatives do you have? 
This is a voluntary participation and has no repercussion should you do not participate. 
The information you provide will be kept confidential and all records destroyed after 
conclusion. There will be no name on the questionnaire only a number will be used to 
guide the data analysis. 
  
What will happen in the unlikely event of some form injury occurring as a direct 
result of your taking part in this research study? 
 
There is no risk of injury related to your participation in this study. 
Will you be paid to take part in this study and are there any costs involved? 
No, you will not be paid to take part in the study.  There will also be no costs involved for 
you, if you do take part. You are freely volunteering to help the student with information for 
her Master’s Degree.  
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Is there any thing else that you should know or do? 
 You can contact Dr EL Stellenberg at: 0219389244. If you have any further queries 
or encounter any problems. 
 You can contact the Committee for Human Research at 021-938 9207 if you have 
any concerns or complaints that have not been adequately addressed by your study 
doctor. 
 If you agree to participate you will be expected to sign the consent form 
 
Declaration by participant 
 
By signing below, I …………………………………..…………. agree to take part in a 
research study entitled “An evaluation of the knowledge of the registered midwives 
managing hypertensive disorders at the Primary Health care Level in the Eastern Cape.   
 
I declare that: 
• I have read or had read to me this information and consent form and it is written 
in a language with which I am fluent and comfortable. 
• I have had a chance to ask questions and all my questions have been 
adequately answered. 
• I understand that taking part in this study is voluntary and I have not been 
pressurised to take part. 
• I may choose to leave the study at any time and will not be penalised or 
prejudiced in any way. 
• I may be asked to leave the study before it has finished, if the study doctor or 
researcher feels it is in my best interests, or if I do not follow the study plan, as 
agreed to. 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2008. 
 
 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2005. 
 
 
 
………………………………………  ……………………………………….. 
Signature of investigator    Signature of witness 
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Declaration by investigator 
 
I (name) ……………………………………………..……… declare that: 
 
• I explained the information in this document to ………………………………….. 
• I encouraged him/her to ask questions and took adequate time to answer them. 
• I am satisfied that he/she adequately understands all aspects of the research, 
as discussed above 
• I did/did not use a interpreter.  (If a interpreter is used then the interpreter must 
sign the declaration below. 
 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2005. 
 
 
 
………………………………………  ……………………………………….. 
Signature of investigator    Signature of witness 
 
 
Declaration by interpreter 
 
I (name) ……………………………………………..……… declare that: 
 
• I assisted the investigator (name) ………………………………………. to explain 
the information in this document to (name of participant) 
…..…………………………….. using the language medium of Afrikaans/Xhosa. 
• We encouraged him/her to ask questions and took adequate time to answer 
them. 
• I conveyed a factually correct version of what was related to me. 
• I am satisfied that the participant fully understands the content of this informed 
consent document and has had all his/her question satisfactorily answered. 
 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2005. 
 
 
Declaration by interpreter 
 
I (name) ……………………………………………..……… declare that: 
 
• I assisted the investigator (name) ………………………………………. to explain 
the information in this document to (name of participant) 
…..…………………………….. using the language medium of Afrikaans/Xhosa. 
• We encouraged him/her to ask questions and took adequate time to answer 
them. 
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• I conveyed a factually correct version of what was related to me. 
• I am satisfied that the participant fully understands the content of this informed 
consent document and has had all his/her question satisfactorily answered. 
 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2005. 
 
 
 
………………………………………  ……………………………………….. 
Signature of interpreter    Signature of witness 
 
 
